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CHAPTER 1 INTRODUCTION 
CHAPTERS CONTAIN MATERIAL FROM PUBLISHED WORK IN WHICH I 
WAS THE FIRST AUTHOR. THE CO-AUTHORS OF THESE PUBLICATIONS 
AGREE TO THE USE OF THE PUBLISHED DATA IN THIS DISSERTATION. 
1.1 Introduction to Arsenic 
Arsenic is a metalloid found in both environmental and occupational settings. 
In the nature world, arsenic ubiquitously exists in rocks, soil, ground waters, air, 
food, and in plants and animals in the form of compounds. Naturally, arsenic 
forms compounds with oxygen, such as oxides (As2O3 and As2O5), sulfides 
(As2S3 and As4S4), as well as compounded with chloride, fluoride, etc. The main 
source of arsenic exposure in environmental settings is through underground 
water, contaminated basically with As5+ salts, arsenates. According to 
epidemiological and etiological studies, the prolonged exposure with low dose 
inorganic arsenic (>500mg/day As3+) in drinking water is highly associated with 
several adverse health effects, such as cardiovascular disorders, nervous 
diseases, diabetes, and also induce renal, hepatic disorders, as well as 
cancers(Gebel 2000). With respect to occupational settings, inorganic arsenical 
exposures are documented to chimney sweepers, smelters, sheep-dip workers, 
and among others (Blejer and Wagner 1976).     
There are multifaceted routes for arsenic exposure, from direct ingestion 
such as drinking and eating, to touching, and even inhalations.  For example, 
welding workers are exposed to welding fumes including inorganic arsenic, and 
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according to previous reports their lungs and other organs are readily to be 
damaged because of inhalations of such fumes (Meo and Al-Khlaiwi 2003). 
Despite of natural arsenicals, there are also artificial synthetic arsenates, such as 
Paris Green for painting pigment, calcium arsenate, and lead hydrogen arsenate, 
used as agricultural insecticides, etc., and with such diversity of arsenicals 
applications the potential for arsenic exposure increases dramatically. 
Accordingly, an estimation of 160 million people is with the risk of arsenic 
exposure worldwide only through water (Joseph, Dubey et al. 2015), let alone the 
whole population of all the pathways for arsenic propagation. 
As what had been reported, cells take up arsenic through different 
membrane transporters, for example, the aquaglyceroporins in human and rat 
cells (Liu, Carbrey et al. 2004), and hexose permeases in Saccharomyces 
cerevisiae (Liu, Boles et al. 2004).  The penetration of arsenate into the cells 
could be achieved through some phosphate transporters(Calatayud, Gimeno et 
al. 2010).  After ingestion, arsenic will be metabolized to its methylated forms, 
monomethyl arsenic acid (MMA) and dimethylarsinic acid (DMA), either 
compounded with trivalent or pentavalent arsenic. With the most updated 
information, its organic metabolites are still carcinogenic (Anetor, Wanibuchi et al. 
2007), but only after metabolism arsenic could be eliminated from system. 
Accordingly, the mechanisms underlying arsenic metabolites include DMA’s 
clastogenic effects (Wanibuchi, Salim et al. 2004), MMA’s ROS-generating 
abilities (Nishikawa, Wanibuchi et al. 2002), etc. In general, inorganic arsenic 
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methylation has been considered as a way to detoxification. However, emerging 
evidence indicates the carcinogenic effects of its metabolites.  
1.2 Arsenic as a carcinogen 
The role of arsenic has been widely studied for decades. Based on cell types 
and its underlying mechanisms, arsenic has been viewed as “Janus-type”. On 
one hand, arsenic had long been considered as an environmental carcinogen. 
On the other hand, as proposed and practiced originally by the traditional 
Chinese medicine, arsenic has been used as a chemo-therapeutic agent for 
acute promyelocytic leukemia (APL). The specific feature of APL is the 
chromosomal translocation, t (15, 17), yields PML-RARα fusion, and arsenic 
targets this fusion, leading to cell death consequently (Chou and Dang 2005).   
The oncogenic activities of arsenic have been documented for several 
decades. The International Agency for Research on Cancer (IARC) reported 
involvement of inorganic arsenic for the increased skin cancer incidence in 1973. 
Following that, IARC updated arsenic carcinogenicity successively in 1980, 1987, 
2004, and 2009(Tokar, Benbrahim-Tallaa et al. 2010), with an expansion to lung, 
urinary bladder, kidney, liver and prostate cancer. The possible mechanisms 
underlying arsenic carcinogenicity are manifold. For example, according to our 
previous studies, arsenic can induce a variety of carcinogenic pathways, 
including a moderate expression of NF-κB (Chen, Ding et al. 2001), MAPK 
proliferative pathways (Chen, Liu et al. 2013, Li, Qiu et al. 2014, Sun, Yu et al. 
2014), Akt activation (Beezhold, Liu et al. 2011, Liu, Chen et al. 2012, Chen, Liu 
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et al. 2013, Li, Qiu et al. 2014, Li, Lu et al. 2015), excessive ROS generation (Li, 
Qiu et al. 2014), as well as regulations of several miRNAs (Beezhold, Castranova 
et al. 2010, Beezhold, Liu et al. 2011, Chen, Liu et al. 2013, Sun, Yu et al. 2014). 
Furthermore, our studies also corroborate that arsenic exposure is associated 
with epigenetic regulations, malignancy control, and cell cycle arrest. In addition, 
we have previously reported that mineral dust-induced gene (mdig), a suspected 
histone demethylase, also responds to arsenic treatment (Sun, Yu et al. 2014), 
leading to changes on the epigenetic landscape of the genome. Overexpression 
of mdig is oncogenic through increasing cancer cell proliferation. However, mdig 
might inhibit migration/invasion of the cells derived from lung cancer or breast 
cancer(Yu, Sun et al. 2014). As for arsenic-induced cell cycle regulations, we 
have proposed that arsenic post-transcriptionally upregulates GADD45 α, a key 
regulator for cells checkpoint functions (Zhang, Bhatia et al. 2006, Chang, Bhatia 
et al. 2007).  Additionally, we have also reported that arsenite causes G2/M cell 
cycle arrest through CDC25C degradation (Chen, Zhang et al. 2002), suggesting 
arsenic is with potential to interrupt cell cycle progression.  Our recent data also 
indicated a positive association between arsenic exposure and cancer cell 
stemness (Chang, Chen et al. 2014). Taken together, arsenic elicits its 
carcinogenic role through regulations on multiple signaling pathways, such as 
NF-κB, MAPK, Akt, ROS, miRNAs, cell cycle, etc.  
1.2.1 Effects of arsenic on NF–κB 
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NF-κB (nuclear factor kappa-light-chain-enhancer of activated B cells) is a 
transcription factor that is responsible for up-regulations of inflammatory 
cytokines, inducible nitric oxide synthesis, superoxide dismutase (MnSOD), anti-
apoptotic genes, growth factors and several oncogenes (Karin 2008).  The NF- 
κb family contains five members, including NF-κB1(p50/p105),  NF-κB2 
(p52/p100),  RelA (p65),  RelB, and c-Rel(Chen, Demers et al. 2002). At the 
resting states, NF- κB is inactivated by its inhibitory partners, IκB family members, 
such as IκBα, IκB β, and IκB ε, in cytoplasm. Once stimulated by arsenic or other 
stresses, IκB will be phosphorylated by its kinase, IKK (IκB kinase), ubiquitinated 
and degraded by proteasome, leading to releasing of NF-κB from the association 
with IκB and translocation of NF-κB to nuclei. A plethora of extracellular stimuli, 
including bacterial products, viral proteins, some carcinogenic metals, and 
reactive oxygen species (ROS), can initiate the upstream signaling for the 
activation of IKK and NF-κB(Li, McGrath et al. 2013). 
There is evidence suggesting that arsenic-induced NF-κB activation might 
be mediated by the excessive generation of ROS (Hu, Jin et al. 2002, Li, Cai et al. 
2002, Henkler, Brinkmann et al. 2010) (Fig. 1.1). As summarized in Figure 1.1, 
arsenic induces excessive generation of ROS from mitochondria and endosomes 
respectively after being taken up through specific transporters as discussed 
above. These ROS further activate NF-κB and other transcription factors, such 
as AP-1 directly (Chowdhury, Chatterjee et al. 2010), or through other nodal 
molecules. For example, the endosomal ROS foster IL-R1 complex recruitment 
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on endosomal membranes and further phosphorylates IKK so that NF-κB is 
activated (Li, Harraz et al. 2006).  However, depending on the duration and 
degree of ROS generation, the oxidative stress induced by ROS may exhibit 
opposite roles on the NF-κB signaling. There are reports demonstrating that the 
release of ROS from mitochondria hampers further NF-κB activation because of 
the extra oxidation on IKK(Kapahi, Takahashi et al. 2000). Without question, NF-
κB is a key mediator for the arsenic-induced carcinogenesis and inflammation 
(Fry, Navasumrit et al. 2007).   
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Figure 1.1 Overview of the effects of arsenic on NF-κB regulations. 
Extracellular arsenic enters into cells through certain transporters on plasma 
membrane. The intracellular arsenic undergoes metabolism, and its reactive 
oxidative metabolites induce the activation of NF-κB and other transcription 
factors. The activated NF-κB translocates into nucleus to regulate expression of 
certain genes to sustain cell growth, transformation and angiogenesis. 
1.2.2 The role of arsenic-induced oxidative stress in carcinogenesis 
As discussed, intracellular arsenic is able to induce oxidative stress. There 
are several types of Reactive Oxygen Species (ROS) and Reactive Nitrogen 
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Species (RNS) generated during arsenic metabolism, including hydrogen 
peroxide (H2O2), hydroxyl radical (HO•), superoxide anion (O2•-), Nitric Oxide 
(NO•), peroxynitrite(Liu and Jan 2000) and some reactive intermediates, such as 
dimethylarsenic peroxyl radical [(CH3)2AsOO•] and dimethylarsinic radical 
[(CH3)2As•] (Del Razo, Quintanilla-Vega et al. 2001). 
Extensive studies have been made on the role of ROS on protein 
modification, lipid oxidation and DNA damage response. An earlier study 
reported that gavage feeding of mice with 220 mg/kg of DMA (Dimethylarsenate) 
induced higher levels of ROS that directly damage DNA, which contributes to the 
further liver carcinogenesis (Wanibuchi, Hori et al. 1997). Furthermore, our 
previous studies also demonstrated that arsenic promotes expression of 
GADD45α, a DNA damage response protein, through the accumulation of ROS 
in the bronchial epithelial cell line, BEAS-2B cells, which supported the notion of 
ROS-related DNA damage (Bower, Leonard et al. 2006). Meanwhile, there is 
evidence indicating that oxidative posttranslational modifications of proteins are 
caused by reactions between free radicals and protein residues(Cai and Yan 
2013), leading to the loss of original function of proteins. Collectively, oxidative 
stress-induced damage on protein, lipid and DNA, and/or the consequent 
damage responses are important contributors to various types of diseases, such 
as cancer, hepatitis and among others. Thus, the abnormal ROS generation 
certainly plays important role of cell transformation and stem cell formation in 
response to arsenic. 
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In our recent studies, we had shown unique patterns of ROS generation in 
the cells subjected to a short-term and long-term treatment with arsenic (Chang, 
Pan et al. 2010). In a short-term treatment, arsenic was highly capable of 
inducing ROS generation in the BEAS-2B cells.  In contrast, the ROS generation 
capacity of the cells with long-term arsenic treatment was significantly 
compromised. Interestingly, the cells following long-term arsenic treatment not 
only showed features of malignant transformation, but also acquired 
characteristics of the cancer stem-like cells. The underlying mechanisms of how 
long-term arsenic treatment reduces ROS generation and such an effect 
contributes to cancer development are still not fully understood. Nonetheless, we 
could make certain plausible speculations. One of those may be due to some 
specific characteristics of the cancer stem-like cells. Several lines of evidence 
had indicated a general reduction of ROS generation in normal stem cells and 
assumed that this is an important measure to maintain the stemness and prevent 
differentiation of the stem cells (Shen, Wang et al. 2015). It is also very likely that 
increased ROS will trigger the p38 and FoxO3 system that drive differentiation of 
the stem cells (Sato, Okada et al. 2014).  Furthermore, either cancer cells, 
cancer stem cells, or normal stem cells, relay on the higher rate of aerobic 
glycolysis (Warburg effect), rather than mitochondrial oxidative phosphorylation 
that produces ROS, for the generation of energy in order to survive the hypoxia 
conditions. More relevant details in this regard will be discussed in chapter two. 
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Nevertheless, overwhelming generation of ROS in normal cells may mediate 
the carcinogenesis of arsenic through oxidative damage of the DNA, lipids and 
proteins, or facilitating genetic mutations due to the interference of the repairing 
processes of the damaged DNA (Fig.1.2).  
 
Figure 1.2 Overview of the effects of ROS on arsenic-induced 
carcinogenesis. Extracellular arsenic gets into cells through certain transporters 
on plasma membrane. The intracellular arsenic undergoes metabolism, and its 
reactive oxidative metabolites will cause damage to protein, lipid and DNA. 
Consequently, the excessive ROS will contribute to arsenic-induced 
transformation of the normal cells, leading to carcinogenesis. 
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1.2.3 Arsenic-induced carcinogenesis through Mitogen-Activated Protein 
Kinase (MAPK) pathway 
A plethora of studies have indicated critical roles MAPK in cell proliferation, 
compensatory growth and malignant transformation of the cells (Chang and Karin 
2001). MAPK is activated through the cascade of MAPK kinase kinase (MEKK), 
MAPK kinase (MEK or MKK) and MAPK, and inactivated by the corresponding 
protein phosphatases (English, Pearson et al. 1999). In mammalian cells, this 
group of kinases includes extracellular signal-related kinases (ERK), Jun amino-
terminal kinases (JNK), and p38. Each of these kinases had been linked to 
carcinogen-induced carcinogenesis or tumorigenesis through different or 
overlapping mechanisms. 
In BEAS-2B cells, our previous studies showed that arsenic is able to induce 
JNK activation and further sustain the expression of Growth arrest– and DNA 
damage–induced gene 45α (GADD45α)(Chen, Lu et al. 2001). The up-regulated 
GADD45α acts as a cell cycle regulator and consequently induces G2/M cell 
cycle arrest. In non-cancerous cells, such as BEAS-2B, cell cycle arrest functions 
more as a negative regulator for cell growth since such arrest will intervene with 
normal mitosis and therefore lead the mitotic cells into the quiescent state. On 
the other hand, for the transformed or cancerous cells it falls into another 
scenario. For the heavily mutated transformed cells such elevated cell cycle 
regulators will also arrest the highly mitotic cells into the quiescent state, but at 
the same time such intervention will provide extra time for those transformed 
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cells undergoing the error-prone repair processes, hence foster cell survival. In 
addition to cell cycle regulations, JNK has also been studied with the ability of 
inducing myc expression stimulated by low dose arsenic treatment, and such 
increased myc may further contribute to arsenic induced cell malignant 
transformation(Chang, Chen et al. 2014). Furthermore, JNK activation has also 
been associated with the phosphorylation and intracellular redistribution of 
Enhancer of Zeste Homolog 2 (EZH2) (Li, Qiu et al. 2014), which will be 
discussed in detail in the next chapter. 
Other members of the MAPK family may be also involved in the oncogenic 
effects of arsenic, for example, the accumulated ROS following arsenic exposure 
are highly capable of promoting ERK activation, therefore, sustain cell 
proliferation(Chowdhury, Chatterjee et al. 2010, Li, Qiu et al. 2014) and 
transformation (Dong 2002, Li, Lee et al. 2011).  With the respect of p38, we had 
also showed a ROS-dependent activation of p38 by arsenic (Li, Qiu et al. 2014). 
Depending on the types of cells and the sub-family members of this kinases, 
activation of p38 can either be pro-carcinogenic or anti-carcinogenic.  When 
p38α was predominantly activated, a cell cycle arrest at the G1/S or G2/M phase 
occurs (Namgung and Xia 2001), which may one of the anti-leukemia 
mechanisms of arsenic.  In contrast, if p38δ was activated, the cells were more 
likely in the proliferative status (Zhong, Lardinois et al. 2011). 
In summary, arsenic can regulate the activation of the MAPK family 
members, possibly through a ROS-dependent mechanism as depicted in Figure 
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1.3. Concordantly with previous studies on biological functions of MAPKs, it is 
likely that MAPKs are the key modulators in the signaling cascades for the 
arsenic-induced cell transformation and carcinogenesis, esp. the JNK kinase. 
Although the pro-apoptotic effect of JNK activation had been extensively studied 
and documented, accumulating evidence also suggested pivotal roles of JNK in 
compensatory growth of the damaged tissues, proliferation of the cancer cells, 
and the maintenance of the stemness of the stem cells or cancer stem-like cells 
through the expression of c-myc, Oct4, Sox2, and other self-renewal 
factors(Chen 2012).   
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Figure 1.3 Overview of MAPK pathways in arsenic biological functions. 
Arsenic exposure will lead to the generation of excessive ROS, and cause 
oxidative stress of the cells, which leads to activation of the MAPK family 
members, ERK, JNK and p38. The activated MAPKs will mediate different 
signaling cascades that play important roles in arsenic-induced carcinogenesis. 
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CHAPTER 2 EPIGENETIC REGULATIONS OF ARSENIC IN TUMORIGENESIS 
CHAPTERS CONTAIN MATERIAL FROM PUBLISHED WORK IN WHICH I 
WAS THE FIRST AUTHOR. THE CO-AUTHORS OF THESE PUBLICATIONS 
AGREE TO THE USE OF THE PUBLISHED DATA IN THIS DISSERTATION. 
2.1 Introduction 
Epigenetics refer to the modifications on genomes without changes in DNA 
sequences. The most typical epigenetic modifications include non-coding RNAs, 
DNA methylation, and histone tail modifications by acetylation, methylation, 
phosphorylation, ubiquitination.  We had previously provided evidence showing 
that arsenic induces EZH2 phosphorylation through ROS/JNK/Stat3/Akt signaling 
cascade. EZH2 is a methyltransferase subunit in the PRC2 complex responsible 
for the tri-methylation of lysine 27 on histone H3 (H3K27me3). There is a report 
suggested that phosphorylated EZH2 might methylate Stat3, leading to a 
sustained Stat3 activation to maintain the stemness of glioblastoma stem cells 
(Kim, Kim et al. 2013). Thus, our studies on the arsenic-induced EZH2 
phosphorylation may unravel an additional mechanism on the carcinogenesis or 
tumorigenesis resulted from environmental arsenic exposure. In our preliminary 
studies, we had provided experimental evidence suggesting that phosphorylated 
EZH2 is able to interact with the cap-independent translation machinery, the 
internal ribosome entry site (IRES) complex to initiate protein translation of c-myc, 
a well-documented oncogene. Furthermore, we have also tested the role of some 
small non-coding RNAs, mostly miRNAs, in the arsenic-induced malignant 
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transformation from the aspects of energy metabolic reprogramming.  Given the 
fact that altered metabolism is considered as a new hallmark of cancer 
process(Hanahan and Weinberg 2011), understanding how arsenic promotes 
metabolic reprogramming will yield new insights into the molecular mechanisms 
and molecular targeting of cancers. 
2.2 EZH2 phosphorylation and intracellular redistribution during arsenic-
induced malignant transformation of the cells. 
Arsenic had been reported to regulate proteins that modify histone tails, and 
contribute to carcinogenesis (Roy, Son et al. 2015). In our previous studies, we 
have demonstrated that arsenic promotes EZH2 phosphorylation at Serine21 
through JNK/Stat3/Akt signaling pathway (Chen, Liu et al. 2013). However, the 
biological significance of this signaling remain to be fully understood.  It has 
been reported that majority of EZH2 proteins are associated the SUZ12, EED, 
and RbAp46.48 to form polycomb repressive complex 2 (PRC2) that transfers 3 
methyl groups to H3K27, and yields gene silencing. Recently, emerging 
evidence also indicates other components of PRC2, such as AEBP2, PCLs and 
JARID2 (Roy, Son et al. 2015). In addition to EZH2, EZH1 that plays a similar 
enzymatic role on H3K27 methylation, can also be incorporated into the PRC2 
complex. Nevertheless, some subtle differences between EZH2 and EZH1 exist. 
For example, EZH1 could be found in the cells in regardless of the proliferative 
status, whereas EZH2 most likely expressed in the highly proliferative cells 
(Margueron, Li et al. 2008). Accordingly, it is not surprising to note an increased 
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expression of EZH2 in various types of cancers (Hock 2012). Meanwhile, 
mounting evidence indicates the fact of arsenic-induced mitochondrial 
dysfunction (Zheng, Lam et al. 2015), resulting in the generation of excessive 
ROS (Reactive Oxygen Species), and the accumulated ROS are highly involved 
in the tumorigenesis process(Prasad, Gupta et al. 2017). Thus, we hypothesize 
that arsenic-induced EZH2 phosphorylation and translocation from nucleus to 
cytoplasm is achieved through ROS/JNK/Stat3/Akt signaling pathway during 
arsenic-induced carcinogenesis. 
In agreement with our earlier report, we observed that arsenic (As3+) is able 
to induce serine 21 (S21) phosphorylation of the EZH2 in human bronchial 
epithelial cell line, BESA-2B cells (Fig. 2.2.1A). To determine the involvement of 
oxidative stress resulted from ROS generation in this As3+-induced EZH2 
phosphorylation, we pre-treated the cells with 20 mM N-acetyl-L-cysteine (NAC), 
a general antioxidant that provides the cells with sufficient amount of glutathione 
to minimize the oxidation of cellular proteins, lipids, and DNA (Sadowska et al., 
2006), for 2h and then treated the cells with 20 μM As3+ for 1,2, or 4 h. A 
significant reduction in EZH2 phosphorylation was noted in the cells treated with 
NAC (Fig. 2.2.1A). NAC is also capable of inhibiting As3+-induced activation of 
Akt, STAT3, and JNK (Fig. 2B and C), the upstream kinases associated with the 
S21 phosphorylation of the EZH2. In addition, NAC is also potent in diminishing 
the As3+-induced activation of ERK and p38 (Fig. 2.2.1D), two mitogen-activated 
protein kinases that respond to the oxidative stress. To validate the contribution 
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of ROS in As3+-induced S21 phosphorylation of the EZH2, we also tested the 
capability of H2O2, one of the most abundant and important ROS, on EZH2 
phosphorylation and kinase activation. Indeed, an earlier occurrence of S21 
phosphorylation of the EZH2 was noted in the cells treated with 0.2mM H2O2 for 
5 to 15 min (Fig. 2.2.1E), which correlates with the time-dependent activation of 
Akt and the dose-dependent Akt activation in the cells treated with different 
concentrations of H2O2 for 5 min (Figs. 2.2.1E and F). 
 
Figure 2.2.1 Involvement of oxidative stress in As3+-induced kinase 
activation and EZH2 phosphorylation in BEAS-2B cells.  
(A) BEAS-2B cells were treated with 20 μM As3 + for 0, 1, 2, or 4 h with or without 
NAC pretreatment for 2 h. S21 phosphorylation of the EZH2 (pEZH2S21) protein 
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was determined by Western blotting. The most right lanes (0 h As3 +) are NAC 
only treatment. (B–D) The activation of Akt (B), STAT3 and JNK (C), and Erk and 
p38 (D) were determined in the BEAS-2B cells treated with 20 or 80 μM As3 + for 
2 h in the presence or absence of NAC pretreatment for 2 h. In each panel, the 
most right lanes (without As3 +, —) are NAC only groups. (E) H2O2 induces 
pEZH2S21 and Akt activation in a time-dependent manner. (F) Dose-dependent 
activation of Akt kinase in the BEAS-2B cells treated with the indicated 
concentrations of H2O2 for 5 min. 
To explore whether the above observations are cell type specific or not, we 
extended this study in other type of cells too. A549 is a cell line derived from the 
non-small cell lung cancer (NSCLC) with some features of alveolar type II cells. 
The S21 phosphorylation of the EZH2 could be observed in the A549 cells 
treated with 20 μM As3+ for 1 to 4 h with a peak phosphorylation at 2 h, which is 
roughly parallel with the pattern of Akt activation by As3+ (Fig. 2.2.2A). A 
significant decrease of both EZH2 phosphorylation and Akt activation in response 
to As3+ was noted in the cells pre-treated with 10 or 20 mM NAC (Fig. 2.2.1A), 
indicating that oxidative stress due to ROS induction by As3+ is also involved in 
the S21 phosphorylation of the EZH2 protein in A549 cells. To address this 
notion further, the A549 cells were treated with different concentrations of H2O2 
for 5 min or 500 μM H2O2 for 5 to 60 min. As depicted in Fig. 2.2.2B, H2O2 is 
capable to induce S21 phosphorylation of the EZH2 along with the activation of 
the upstream kinases, including JNK, STAT3, and Akt. To extend above 
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observations, we also tested the inducibility of EZH2 phosphorylation by As3+ at 
much lower concentrations from 0.25 to 4 μM in the cells cultured for a prolonged 
time, 72 h. We noted that lower concentrations of As3+ was able to induce JNK 
and p38 activation in a clear dose-dependent manner (Fig. 2.2.2C and data not 
shown). However, a significant Akt activation by lower concentrations of As3+ 
could not be detected (top two panels, Fig. 2.2.2C). The treatment of the cells 
with 0.25 or 2 µm As3+-induced S21 phosphorylation of EZH2 (Fig. 2.2.2D). 
Unexpectedly, NAC appeared to be unable to inhibit the EZH2 phosphorylation 
induced by As3+ at lower concentrations. In other experiments, we demonstrated 
that prolonged incubation of the cells with NAC, e.g., 72 h, enhanced both basal 
and As3+-induced p38 activation, possibly because of stress responses due to 
the overwhelmed reduction condition. Accordingly, we speculate that different 
mechanisms may be involved in the EZH2 phosphorylation induced by low and 
high concentrations of As3+, respectively. 
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Figure 2.2.2 Oxidative stress contributes to As3 +-induced EZH2 
phosphorylation and kinase activation in A549 cells 
(A) A549 cells were treated with 20 μM As3 + for the indicated time with or without 
NAC pretreatment for 2 h. The levels of pEZH2S21 and Akt activation were 
determined by Western blotting. The NAC only groups were indicated as 0 h 
As3 + treatment. (B) Dose- and time-dependent EZH2 phosphorylation and 
kinases activation in A549 cells treated with H2O2. (C) Lower concentrations of 
As3 + induce JNK but not Akt activation in the A549 cells treated with As3 + for 
72 h. (D) NAC was unable to inhibit lower concentration As3 +-induced EZH2 
phosphorylation in the cells cultured for 72 h. 
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In BEAS-2B cells, we had previously shown the cytoplasmic translocation of 
the S21-phosphorylated endogenous EZH2 from nuclei in response to As3+ 
treatment (Chen et al., 2013). To investigate if As3+ is able to induce the same 
translocation of the exogenous EZH2, the BEAS-2B cells expressing GFP-EZH2 
were treated with 20 μM As3+ for 2 h. The GFP-EZH2 is exclusively localized in 
the nuclei of the cells without As3+ treatment (Fig. 2.2.3 A, upper panels). 
Following As3+ treatment, both cytoplasmic and nuclear locations of the GFP-
EZH2 were observed (Fig. 2.2.3 A, bottom panels). Furthermore, As3+ appeared 
to be able to induce the clustering of GFP-EZH2 proteins. These clusters were 
randomly distributed in both cytoplasm and nucleus. To explore whether 
oxidative stress is involved in As3+-induced re-distribution of the GFP-EZH2, 
NAC was applied prior to As3+ treatment. As shown in Fig. 2.2.3 B, NAC 
prevented the cytoplasmic localization of the GFP-EZH2 induced by either 20 
μM or 80 μM As3+, indicating that the oxidative stress is involved in As3+-induced 
cytoplasmic localization of the EZH2 protein. However, NAC was unable to 
prevent the nuclear clustering of the exogenous GFP-EZH2 proteins induced by 
As3+. The possible role of oxidative stress on the intracellular distribution of the 
EZH2 protein was confirmed by the treatment of the cells with 0.2 mM H2O2 that 
clearly induced cytoplasmic localization of the GFP-EZH2 proteins (Fig. 2.2.3 B, 
bottom panels). Semi-quantification suggested a more than 50% inhibition of the 
As3+-induced cytoplasmic localization of the exogenous EZH2 (GFP-EZH2) by 
NAC (Fig. 2.2.3 C). To further confirm the effect of As3+ and/or oxidative stress 
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on the cytoplasmic localization of the EZH2 proteins, we fractionated the cell 
lysates by isolating cytoplasmic and nuclear fractions, respectively, followed by 
measuring the levels of S21-phosphorylated and the total endogenous EZH2 
proteins in response to As3+ or H2O2 treatment. Although As3+ appeared to be 
unable to affect the nuclear levels of the phosphorylated EZH2 (pEZH2) and 
EZH2, As3+ was able to increase both pEZH2 and EZH2 in the cytoplasmic 
fraction (Fig. 2.2.4 A). The pretreatment of the cells with 20 mM NAC reduced 
As3+-induced pEZH2 in the cytoplasmic fraction significantly. NAC was also able 
to reduce the level of total EZH2 in the cytoplasmic fraction, although with a 
lesser extent relative to its effect on the phosphorylated EZH2. 
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Figure 2.2.2 Both As3 + and H2O2 induce cytoplasmic localization of the 
EZH2 protein in BEAS-2B cells. 
(A) BEAS-2B cells expressing GFP-EZH2 were treated with 20 μM As3 + for 2 h. 
The intracellular distribution of EZH2 was determined by immunofluorescent 
microscopy. (B) NAC prevented cytoplasmic localization of the EZH2 protein 
induced by As3 + in BEAS-2B cells transfected with GFP-EZH2. H2O2 was used 
as a control of ROS. (C) Statistical analysis of the cytoplasmic translocation ratio 
of the EZH2 protein in the cells treated with As3 + in the presence or absence of 
NAC. Data are expressed as the mean ± SD, n = 3, ** p < 0.05. 
H2O2 could transiently induce the increase of both phosphorylated and total 
EZH2 in the cytoplasm (Fig. 2.2.4 B). However, this effect of H2O2 was rapidly 
diminished after 10 min of H2O2 treatment, possibly due to the fast elimination of 
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H2O2 by the medium, the cellular peroxisomes that contain catalase and the 
cytoplasmic glutathione peroxidase (GPx) and NADPH (Makino et al., 2004). 
 
Figure 2.2.4 Increased cytoplasmic localization of the phosphorylated and 
total EZH2 in BEAS-2B cells treated with As3 + or H2O2. 
(A) BEAS-2B cells were treated with 20 or 80 μM As3 + for 2 h with or without 
NAC pretreatment. Cellular fractions were made to extract the cytoplasmic and 
nuclear proteins. Lamin A/C and GAPDH were used as indications of the nuclear 
and cytoplasmic fractions. Lanes 4 and 10 are NAC only groups. Right panel 
shows semi-quantification of the ratio between pEZH2 and EZH2 in the 
cytoplasm. (B) BEAS-2B cells were treated with 0.2 mM H2O2 for the indicated 
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times. The levels of phosphorylated EZH2, total EZH2, lamin A/C, and GAPDH 
were determined in the cytoplasmic and nuclear fractions, respectively. Right 
panel shows semi-quantification of the ratio between pEZH2 and EZH2 in the 
cytoplasm. 
So far, our hypothesis on the arsenic-induced EZH2 phosphorylation and 
cytoplasmic translocation is through ROS accumulation has been confirmed, 
whereas the direct connection of such biological event with cell malignant 
transformation has not yet been established, thus for the next steps we 
investigated the oncogenic relevance of arsenic-induced EZH2 phosphorylation 
and further compartmental re-localization. To construct the association of such 
biological event with oncogenic properties or transformed features, we first 
focused on the probable contributions of cytoplasmic pEZH2 on malignant 
transformation. We had reported that chronic exposure of sub-lethal arsenic to 
BEAS-2B cells will lead to the malignant transformation, and those transformed 
BEAS-2B cells acquired some features of the cancer stem cells, such as 
increased expression of Oct4, Sox2, Klf4, and Myc (Chang, Chen et al. 2014). 
Prompted by such findings, it’ll be important to investigate the association of 
pEZH2 and the expression of the stemness markers. 
Cancer Stem Cells (CSCs) refer to a small population of tumor cells that 
have the ability of both self-renewal and differentiation (Bjerkvig, Tysnes et al. 
2005). Reports indicate that CSCs are the key for tumor initiation, progression, 
therapeutic resistance, and metastasis (Jiang, Li et al. 2014). Thus, we 
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hypothesize that arsenic-induced pEZH2 through oxidative stress may contribute 
to the acquisition of CSC traits. A growing body of evidence supports that c-myc, 
one of the key genes for the self-renewal of the CSCs. It has been shown that 
the 5’-UTR of c-myc mRNA contains an Internal Ribosome Entry Site (IRES) 
sequence that confers its expression independent to the canonical cap-
dependent protein translation process (Stoneley, Paulin et al. 1998, Chappell, 
LeQuesne et al. 2000, Shi, Sharma et al. 2005). Since we observed cytoplasmic 
localization of the pEZH2, and there are reports suggesting c-myc upregulation 
by EZH2, one of the biological function of pEZH2, thus, may promote c-myc and 
other protein translation through the cap-independent, but IRES-dependent 
translation.  
The IRES refers to a specific nucleotide sequence in the 5’-UTR region of 
mRNA enabling the cap-independent translation. The IRES-mediated cap-
independent translation is a common biological event in virus, albeit the 
mechanisms in cells are still under investigation(Komar and Hatzoglou 2011), 
and our present study provides preliminary data suggesting the role of pEZH2 in 
up-regulating c-myc expression through the IRES, the non-canonical translation 
mechanism for the first time. In general, the IRES-dependent translation 
translates proteins when the cells are in growth-arresting and/or apoptotic states.  
Under these growth disadvantage conditions, the factors important for cap-
dependent translation, such as eIF4B, eIF3, eIF2a, and eIF4Gs, are either been 
degraded or functionally inhibited.  When a given mRNA is subjected to IRES-
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dependent translation, the canonical initiation factors are dispensable. It is 
believed that a direct interaction between the IRES and the 40S ribosome occurs 
along with the so-called IRES trans-acting factors. Well documented evidence 
suggests that about 10% mRNAs can manage to escape the translational 
depression circumstances and maintain translation through the cap-independent, 
namely the IRES pathway (Kozak 2005). To test our hypothesis on the 
association of cytoplasmic pEZH2 and c-myc expression, we examined the 
expression of c-myc for both mRNA and protein levels in the cells Akt I and Akt II, 
two kinases responsible for EZH2 phosphorylation, was silenced by siRNAs. As 
depicted in Fig. 2.2.5, Akt silencing is accompanied with a significant decrease of 
the basal and arsenic-induced c-myc proteins without changes of the c-myc 
mRNA, indicating that translational, rather than transcriptional regulation of the 
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Akt signaling on c-myc expression. 
 
Figure 2.2.5 Involvement of Akt in arsenic-induced c-myc expression. 
(A), BEAS-2B cells were transfected with 50nM Control or Akt I siRNAs 24hours 
before treatment with 20µM arsenic for 2 hours. The expression of the indicated 
proteins with determined by Westernblotting. Right panel show c-myc mRNA 
levels determined by qRT-PCR. (B), BEAS-2B cells were under the similar 
treated as described in (A) with the silencing of Akt II mRNA. 
To determine whether Akt regulation on c-myc is through EZH2 
phosphorylation and IRES mechanism, we overexpressed a mutated EZH2 in 
which the serine 21 (S21) was substituted by alanine (S21A) in the BEAS-2B 
cells. Meanwhile, we also overexpressed another mutated EZH2 in which the 
S21 was replaced by aspartic acid EZH2 (S21D) that mimics the structure of 
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pEZH2 on S21. Indeed, the EZH2 S21A was mostly localized in the nuclei of the 
cells, and EZH2 S21D can be found in both cytoplasm and nuclei (Fig. 2.2.6). 
Meanwhile, the Western blot analysis also indicates an increased cytoplasmic 
myc-EZH2 level in the S21D transfected group. These data confirmed our 
previous findings suggesting that the pEZH2 is more likely to be translocated in 
to the cytoplasm.  
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Figure 2.2.6 Cytoplasmic localization of pEZH2. 
(A), BEAS-2B cells were transfected with either myc-EZH2 S21A or S21D mutant 
constructs, with or without 20µM As3+ exposure for 2 hours. The transfected cells 
are further immunostained with myc-tag antibody for microscopic observation 
and analysis (C). (B), the cytoplasmic and nuclear proteins of the BEAS-2B cells 
transfected with EZH2 S21A or S21D mutant were isolated separately followed 
by Westernblotting. 
As depicted in Figure 2.2.7A, despite S21 was mutated to A, arsenic was still 
able to induce EZH2 phosphorylation, indicating that phosphorylation at other 
sites may occur. Nevertheless, more induction of c-myc protein as well as it 
down-stream targeting protein mdig. Again, there appeared to be no difference 
on the c-myc mRNA levels between the cells expressing EZH2 S21A and EZH2 
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S21D.  We also transfected the transformed BEAS-2B cells with EZH2 S21A and 
EZH2 S21D, respectively. However, a similar level of c-myc protein was noted 
between the cells expressing EZH2 S21A and EZH2 S21D. 
 
Figure 2.2.7 pEZH2 up-regulates c-myc protein. 
(A), BEAS-2B cells were transfected with EZH2 S21A mutant plasmid or EZH2 
S21D mutant plasmid 24hours, followed by the treatment with 20µM arsenic for 2 
hours. The indicated protein levels were determined by Westernblotting. (B), 
BEAS-2B cells were under the same treatment as described in (A), and the c-
myc mRNA levels were measured by qRT-PCR. (C), Transformed BEAS-2B cells 
were transfected and treated as the same of the BEAS-2B cells.  
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The above results are in line with our hypothesis that arsenic-induced EZH2 
phosphorylation may up-regulate c-myc protein expression through the IRES-
dependent translation. To further address this point, we co-transfected the 
BEAS-2B cells with an IRES-dependent luciferase reporter vector and EZH2 
S21A or EZH2 S21D (Fig. 2.2.8). The IRES-dependent luciferase reporter, pRMF, 
contains c-myc 5’UTR IRES element at the upstream of firefly luciferase, thus if 
the c-myc IRES is activated by pEZH2 there will be an increased firefly luciferase 
luminescence. In the first experiment, we cultured the cells in 5% FBS and then 
treated with 20µM arsenic. However, we didn’t observe an increased c-myc IRES 
luciferase activity in the cells expressing EZH2 S21D (Figure 2.2.8A). As we had 
discussed earlier, the IRES-dependent protein translation occurs most likely 
during the stress condition, such as growth arrest and apoptosis. Thus, we next 
cultured the cells in 0.5% FBS medium and test the luciferase activities.  Indeed, 
an enhanced luciferase activity was observed in the cells expressing EZH2 S21D 
relative to the cells expressing EZH2 S21A (Figure 2.2.8A), further suggesting 
that pEZH2 may promote the IRES-mediated cap-independent translation of the 
c-myc protein. We speculate that this IRES-based c-myc translation may offset 
the stress-induced cell death signals. It is true. Cell viability assay using MTT 
absorption indicated more viable cells of the cells expressing EZH2 S21D than 
the cells expressing EZH2 S21A (Figure 2.2.8B) 
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Figure 2.2.8 pEZH2 up-regulates c-myc through IRES. 
(A) Plasmid containing the IRES element of c-myc, pRMF, was transfected into 
BEAS-2B (B2B) cells along with EZH2 S21A or EZH2 S21D EZH2.  The 
luciferase activity was determined for the cells cultured in 5% FBS or 0.5% FBS. 
(B) pEZH2 improves cell viability. BEAS-2B cells were transfected with either 
EZH2 S21A or EZH2 S21D and cultured in 0,5% FBS for 24hours. At the end of 
this culture, cells were subjected to MTT assay to measure the cell viability. 
***p<0.005, #p<0.001.  
Taken together, above data suggest that the biological consequences of 
EZH2 phosphorylation are the cytoplasmic translocation of pEZH2. In the 
cytoplasm, pEZH2 participates in the IRES-mediated, cap-independent protein 
translation, such as c-myc. Although other mechanisms can not be ruled out, the 
arsenic-induced c-myc expression may be achieved partially through EZH2 
phosphorylation and cytoplasmic localization of the pEZH2, which further 
enhances IRES-dependent c-myc protein translation. Since c-myc is one of the 
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pivotal factors for the malignant transformation and generation of the CSCs, the 
findings of arsenic-induced EZH2 phosphorylation may be more carcinogenic 
than its non-phosphorylated counterpart. 
2.3 Involvement of mi-R214/199a cluster in arsenic-induced cell malignant 
transformation. 
Similar to siRNA, miRNA is a family of small non-coding RNAs that will bind 
to 3’-UTR region of specific mRNA through base-pairing, leading to translational 
repression.  This group of non-coding RNAs are also able to bind to the open-
reading-frame (ORF) or 5’-UTR of mRNAs to induce mRNA degradation, 
depending on the degree of complementarity. Per the functions of proteins 
translated from mRNAs that are targeted by miRNAs, miRNAs can be further 
categorized to tumor suppressor miRNAs and oncomirs. Tumor suppressor 
miRNAs refer to miRNAs that target mRNAs of oncogenes or growth factors, 
whereas oncomirs are those miRNAs that can target tumor suppressors. To 
investigate which groups of miRNAs can be regulated by arsenic, we profiled 
miRNA expression through both DNA microarray and miRNA microarray for the 
control BEAS-2B cells and the transformed BEAS-2B cells induced by a six-
month arsenic treatment.  Table 2.3.1 listed miRNAs that have more than five-
fold over-expression in the transformed BEAS-2B cells compared with the control 
BEAS-2B cells.  Among these up-regulated miRNAs, the highest expressed 
miRNAs are from the miR-214/199a cluster, suggesting the possible oncogenic 
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roles of these miRNAs in arsenic-induced malignant transformation and 
carcinogenesis. 
miRNAs Name Fold-Change(Transformed BEAS-2B 
vs. BEAS-2B 
hsa-miR-214-3p 345.978 
hsa-miR-199a-3p 121.017 
hsa-miR-199a-5p 40.759 
hsa-miR-145-5p 13.9976 
hsa-miR-10b-5p 11.4962 
hsa-miR-196b-5p 11.2852  
hsa-miR-34b-3p 9.39436 
hsa-miR-10b-5p 9.06381 
hsa-miR-146b-5p 8.39626 
Table 2.3.1 Fold changes of miRNAs in Transformed BEAS-2B and BEAS-
2B cells 
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MiR-214/199a cluster is located in the opposite strand of intron 14 of 
dynamin 3 genes, DNM3os, and can be co-transcribed with the host gene or 
transcribed as an independent transcript (Watanabe, Sato et al. 2008). Limited 
information is available on the role of miR214/199a in human diseases or cancer. 
Few earlier studies that miR-214 and miR-199a potentiate the oncogenic roles of 
Twist (Yin, Chen et al. 2010) and TGF-β1 (Kuninty, Bojmar et al. 2016). The 
highest expression of miR-214 and miR-199a in the arsenic-transformed cells 
suggest to us that these two microRNAs may be important in mediating arsenic-
induced malignant transformation of the cells. 
To validate the microarray data, we first quantified expression of tested miR-
214/199a in BEAS-2B and the transformed BEAS-2B through quantitative real-
time PCR (qRT-PCR).  As indicated in Figure 2.3.1, both miR-214 and miR-199a 
exhibited more than 6,000-fold overexpression in the transformed BEAS-2B cells 
relative to the control BEAS-2B cells. In a separate experiment, we also 
quantified miR-199a-5p and -3p, respectively. Again, a more-than 5,000-fold 
overexpression of both -5p and -3p was noted in the transformed BEAS-2B cells. 
Although both -5p and -3p are from the same pri-miR-199a but derived from the 
opposite strands, the level of -5p is much higher, about 25,000-fold higher in the 
transformed BEAS-2B cells than the control BEAS-2B cells, possibly suggested 
differences between miR-199a-5p and miR-199a-3p in their stability and 
targeting efficiency. Interestingly, both miR-214 and miR-199a were not induced 
by a short-term arsenic treatment.  We treated the control BEAS-2B cells with 20 
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µM arsenic for 2 hours. However, no induction of miR-214, nor miR-199a, was 
observed, suggesting a more complicated mechanism is involved in the 
regulation of the miR-214/199a cluster by arsenic. 
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Figure 2.3.1 Involvement of miR214/199a cluster in arsenic-induced 
malignant transformation. 
(A), the expression of mi-R214 and miR-199a were determined in both BEAS-2B 
(B2B) and Transformed BEAS-2B cells (TB2B) through qRT-PCR. (B), in BEAS-
2B and Transformed BEAS-2B cells, the expression of miR199a-5p -3p were 
tested as described in (A). (C & D), The expression of miR199a-3p, -5p and miR-
214 were measured in BEAS-2B cells (C) and Transformed BEAS-2B cells (D) 
treated with 20µM arsenic for 2 hours. * p<0.05, **p<0.01. 
The inability of short-term arsenic treatment to induce miR-214 and miR-
199a expression might be due to the factors of arsenic concentrations. To clarify 
this consideration, we performed a dose-response study through treating the 
cells with different concentrations of arsenic for 2 or 72 hours.  Again, we did not 
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observe a significant induction of miR-214 and miR-199a in these additional 
short-term experiments (Figure 2.3.2)  
 
Figure 2.3.2 Influences of short-term arsenic exposure on miR-214 and 
miR-199a. 
(A), BEAS-2B cells were treated with 5 to 80 µM arsenic for 2 hours; (B), BEAS-
2B cells treated with 0.25 to 4 µM arsenic for 72 hours.  The levels of miR-214 
and miR-199a were determined by qRT-PCR.  
One of the possibilities that only long-term arsenic treatment is able to 
induce miR-214 and miR-199a is that transcription of these miRNAs needs some 
epigenetic changes to cluster located in DNM3os. The most common epigenetic 
regulation on gene transcription includes DNA methylation and histone 
modifications, such as acetylation and methylation. Histone acetylation has 
viewed as a positive marker for transcription (Shukla, Vaissiere et al. 2008), 
whereas DNA hypermethylation, in general, inhibits transcription (Akhavan-Niaki 
and Samadani 2013). To that end, we treat BEAS-2B cells with either DNA 
methyltransferase inhibitor, 5-Aza-2ʹ-Deoxycytidine (5-Aza), or histone 
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deacetylase inhibitor, Trichostatin A (TSA) for 72 hours, followed by the 
measurement of miR-214 and miR-199a through qRT-PCR. As shown in Figure 
2.3.3, the inhibition of DNA methylation by 5-Aza can promote the expression of 
miR-214 and miR-199a-3p, and also enable the induction by arsenic, whereas 
enhancement of histone acetylation by TSA-based inhibition of the HDACs only 
showed marginal effect on miR-199a and miR-214. 
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Figure 2.3.3 Role of DNA methylation and histone acetylation in miR-
214/199a expression. 
(A), BEAS-2B cells were treated with 5-Aza-2ʹ-Deoxycytidine (5-Aza) of the 
indicated concentrations for 72hours, and the expression of miR-214 and miR-
199a-3p were quantified by qRT-PCR. (B), BEAS-2B cells were co-treated with 
10µM 5-Aza-2ʹ-Deoxycytidine and the indicated concentrations of arsenic for 
72hours, followed by qRT-PCR for miR-214 and miR-199a. (C), BEAS-2B cells 
were treated with Trichostatin A (TSA) with the indicated concentrations for 72 
hours and then measured for histone H3 acetylation by Westernblotting. (D), 
miR-214 and miR-199a were determined by qRT-PCR in the cells treated with 
TSA.  *p<0.05. 
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Above data clearly suggest to us that miR-214 and miR-199a must play key 
roles in the arsenic-induced malignant transformation through serving as 
oncomirs. It has been known many oncomirs facilitate or promote oncogenesis 
by down-regulating tumor suppressors, DNA repair proteins, pro-apoptotic 
proteins. To investigate how miR-214 and miR-199a contribute to the arsenic-
induced cell transformation, we developed a comprehensive strategy that 
contains 3 different steps. At the first step, we performed a bioinformatics mining 
using 4 different databases to predict the targets of miR-214 and miR-199a, 
including PITA, MicroRNA.org, Targetscan, and Diana-microt. Since our previous 
studies already revealed a reduced capacity of ROS induction in the arsenic-
induced transformed cells (Chang, Pan et al. 2010), we paid special attention to 
those targets that are involved in ROS generation, mitochondrial function and 
energy metabolism. We found all 4 databases predicted both miR-214 and miR-
199a can bind to the 3’-UTR of mitochondrial transcription factor A (TFAM). The 
PITA program even predicted multiple miR-214 and miR-199a binding sites in the 
3’-UTR of TFAM, which promoted us to the second step to evaluate whether 
there are direct physical interactions of TFAM 3’-UTR and miR-214/199a. For 
that purpose, we transfected the cells with a luciferase reporter construct 
containing the whole 3’-UTR of TFAM along with precursors or antagomirs for 
miR-214 and miR-199a. As indicated in Fig 2.3.4, the luciferase activity is 
decreased in the cells transfected with miR-214/199a precursors as compared 
with the cells transfected with antagomirs (inhibitors of miR-214 or miR-199a). 
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These results confirmed the hypothesis that there are direct interactions of both 
miR-214 and miR-199a with the TFAM 3’-UTR.  
 
Figure 2.3.4 TFAM is a direct target miR-214 and miR-199a. 
BEAS-2B cells were transfected with either miRNA inhibitor or precursor for 
24hours, followed by an additional 24hours’ culture. At the end of cell culture, 
total cell lysates were used for luciferase activity assay. *p<0.05, **p<0.01, 
***p<0.005. 
At the third step, we measured the protein levels of TFAM along with few 
other mitochondrial proteins, including ND-1, a protein in the mitochondrial 
respiratory chain and encoded by the mtDNA (mitochondrial DNA), as well as 
ATP5a and VDAC, which are the typical mitochondrial housekeeping proteins 
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(Fig 2.3.5). The reason why we focused on the mtDNA-encoded proteins is 
based on the functional consideration of TFAM. It has been well-established that 
TFAM can sustain mtDNA replication and transcription by binding to the different 
regions on mtDNA(Ramos, Santos et al. 2009), thus if miR-214/199a targets 
TFAM, then the expression of mtDNA-encoded protein should be affected also. 
The TFAM was readily detected in the control cells.  However, we failed to detect 
the TFAM protein in the arsenic-induced transformed cells were exhibited 
overwhelming miR-214 and miR-199a expression (Figure 2.3.5). The 
transformed cells also showed a notable decrease of the expression of ND-1 
protein, whereas ATP5a expression was comparable between the control BEAS-
2B cells and the transformed cells. Interestingly, VDAC, the mitochondrial 
membrane protein, was expressed much higher in the transformed cells. 
 
Figure 2.3.5 Decrease of mitochondrial proteins in the arsenic-induced 
transformed-B2B cells. 
(A) The BEAS-2B (B2B) and Transformed BEAS-2B (T-B2B) cells were treated 
with low dose arsenic as indicated for 72 hours and tested for the protein levels 
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through Westernblotting using the specific antibodies. (B) Higher concentrations 
of arsenic were used for a two-hour treatment of the B2B and T-B2B cells. The 
protein expression determined as described in (A). 
Furthermore, we also determined the copy numbers and transcription of 
mtDNA by PCR in both control cells and the arsenic-induced transformed cells.  
We used 4 sets of PCR primers to amplify different regions of mtDNA as reported 
by Ramos et al (Ramos, Santos et al. 2009). As depicted in Figure 2.3.6, a 
substantial decrease of mtDNA copy number and transcription was observed in 
the transformed cells, which is in line with the observed decrease of TFAM and 
increased expression of miR-214 and miR-199a in the transformed cells. 
Although transfection of the cells with miR-214/199a inhibitors did not recover 
mtDNA in the transformed cells. The inhibitors did recover TFAM in the control 
BEAS-2B cells.  
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Figure 2.3.6 Regulations of miR214/199a on mtDNA. 
(A), Transcription and replication of mtDNA (cDNA) are determined with the 
primers for different regions on mtDNA (1, 2, 3, 8) in BEAS-2B (B) and 
Transformed BEAS-2B (T) cells. (B), Recovery test of mtDNA transcription and 
replication was measured in the control BEAS-2B (B2B) and Transformed BEAS-
2B (T-B2B) cells transfected with miR-214 or 199a precursor (pre) or inhibitor 
(anti). Further protein level of TFAM in B2B and T-B2B cells were tested with the 
additional miR-214 (C), and miR-199a (D) precursor or inhibitor transfection. 
Above data have revealed overexpression of miR-214/199a in the arsenic-
induced transformed BEAS-2B cells. These data also provided evidence showing 
that during the arsenic-induced BEAS-2B cells transformation, the increased 
miR-214/199a can target TFAM to down-regulate the protein level of TFAM in the 
transformed cells. Since mitochondrial is the central organelle for glucose and 
48 
 
 
 
lipid metabolism, decrease of TFAM by miR-214 and miR-199a will impair the 
replication, transcription and stability of the mtDNA, leading to malfunction of the 
mitochondrial metabolism. Thus, it is important to determine is there a metabolic 
reprogramming in the arsenic-induced transformed cells.  
A number of studies revealed unique metabolic features of the cancer cells, 
stem cells or cancer stem-like cells (CSCs). In general, some of the transformed 
cells and CSCs exhibit downregulation of mitochondrial respiratory chain 
complexes, reduction in mtDNA copy number and the immature state of the 
mitochondria, leading to a reduced oxidative phosphorylation (OXPHOS) and 
citric acid cycle/tricarboxylic acid (TCA) cycle and an increase in glycolysis (Xu, 
Duan et al. 2013, Ciavardelli, Rossi et al. 2014).  How mitochondrial function and 
OXPHOS were impaired or inhibited in transformed cells or CSCs is still a 
mystery. Meanwhile, majority of these studies view this metabolic shift as a 
byproduct of the cell fate status. In fact, some recent studies had shown that 
several metabolites from either glycolysis or mitochondrial OXPHOS may be 
active regulators for the epigenetic modifications and transcriptional regulation 
involved in self-renewal and lineage commitment of the transformed cells or 
CSCs, e.g., NAD+ and S-adenosyl methionine (SAM) from glycolysis, acetyl-
CoA, α-ketoglutarate (α-KG) and flavin adenine dinucleotide (FAD) from 
OXPHOS/TCA, are important co-factors or regulators for histone acetylation or 
deacetylation, histone and DNA methylation or demethylation. Furthermore, O-
linked N-acetylglucosamine (O-GlcNAc), a product of subsidiary pathway from 
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glycolysis, may be essential for the O-GlcNAcylation and activation of Oct4 and 
Sox2, two key factors for the self-renewal of stem cells and CSCs (Jang, Kim et 
al. 2012).  
To directly demonstrate the metabolic shift, we conducted metabolomics 
study of the cells by using both 13C glucose flux and untargeted global 
metabolomics (metabolome) through the DiscoveryHD4 platform for the 
maximum coverage of the detected changes of metabolites between the control 
cells and As3+-induced transformed cells. In 13C glucose flux assay, we detected 
increased glycolytic intermediates G6P/F6P (glucose-6-phosphate/fructose-6-
phosphate), FBP (Fructose-bisphosphate), PEP (phosphoenolpyruvate), 
2PG/3PG (2-phosphoglycerate/3-phosphoglycerate combined), R5P/X5P 
(Ribulose 5-phosphate/xylulose 5-phosphate), and others in the transformed 
cells (Figure 2.3.7). Metabolome study revealed a substantial decrease in the 
energy (TCA/OXPHOS) metabolism in the As3+-induced transformed cells 
relative to the control cells (Figure 2.3.8A). As compared with the control or the 
cells treated with 0.25 µM As3+ for 3 days, the most significantly decreased 
TCA/OXPHOS metabolites in the transformed cells include succinylcarnitine (C4-
DC), aconitate (ACO), α-ketoglutarate (α-KG), citrate (CIT), and fumurate (FUM). 
(Figure 2.3.8B). However, in a short-term treatment of the BEAS-2B cells with 
0.25 µM As3+ for 3 to 7 days, we observed a time-dependent decrease of FUM 
and MAL, and a time-dependent increase of CIT and α-KG (Figure 2.3.8C). 
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Figure 2.3.7. Changed metabolites in BEAS-2B cells and transformed cells 
as detected by 13C-Glucose Flux (triplicates of each group). 
B: BEAS-2B; T: Transformed cells. 
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Figure 2.3.8. Altered global metabolomics in transformed cells. 
(A) Heat map of metabolites of the control cells treated with 0.25 µM As3+ for 0, 3, 
or 7 days and the As3+-induced transformed cells, n=6; (B) Decreased 
metabolites in TCA cycle in transformed cells. The sizes of blue circles indicate 
degrees of decrease. (C) Actual values of the TCA metabolites among the tested 
cells as indicated. T: transformed cells. 
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2.4 Discussion  
The aim of this dissertation was to explore how arsenic induces cell 
malignant transformation, by focusing on the epigenetic regulation, such as 
histone methyltransferase EZH2 phosphorylation, miRNA expression and 
metabolic changes of the cells in response to arsenic treatment. Abnormalities in 
epigenetic regulation have been linked to a number of human diseases, the 
initiation, progression and other pathogenesis of cancers. The most studied 
epigenetic mechanisms include DNA methylation, miRNAs, histone methylation, 
histone acetylation, histone phosphorylation, histone ubiquitination, histone 
sumoylation, histone biotinylation, etc. (Wang, Xin et al. 2016). In this dissertation, 
much effort was made on arsenic-induced ROS generation that was linked to 
EZH2 phosphorylation and the subsequent IRES-dependent translation of the 
oncogene c-myc.  
We provided evidence showing that the oxidative stress due to ROS 
generation contributes to As3+-induced kinase activation that leads to S21 
phosphorylation of the EZH2 protein. Meanwhile, oxidative stress appears to be 
able to induce cytoplasmic localization of the phosphorylated EZH2 protein in the 
cells treated with As3+. Pretreatment of the cells with NAC prevented EZH2 
phosphorylation and cytoplasmic localization induced by As3+. EZH2 is the 
enzymatic component that forms polycomb repressive complex 2 (PRC2) with 
EED, SUZ12, RbAp46/48, and possibly other proteins. PRC2 catalyzes the 
trimethylation of lysine 27 of histone H3 (H3K27me3), a mark of transcriptionally 
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silent or poised chromatin (Margueron and Reinberg, 2011). In the past few 
years, EZH2 had been the focus of a significant number of biochemical and 
molecular studies in cancer cells and cancer stem cells. Many independent 
studies revealed that EZH2 is overexpressed in several common cancers and 
that the degree of EZH2 overexpression is associated with the aggressiveness of 
these tumors (Hock, 2012). Such an overexpression of EZH2 was viewed as a 
major causative force, rather than a result, of the cancer development. Some 
genetic studies suggested that missense mutation in the catalytic domain causes 
hyperactivation of the EZH2 protein and increased incidents of malignancies, 
such as neuroblastoma and lymphoma (Crea, 2012). Additional evidence also 
indicated that the overactivation of EZH2 is responsible for the increased 
aggressiveness of the breast cancer associated with the loss of BRCA1 tumor 
suppressor (Wang and Huang, 2013). In human prostate cancer, EZH2 is one of 
the most important oncogenic factors for the initiation and progression of the 
tumor, as revealed by the fact that the inactivation of EZH2 by chemical inhibitor 
DZNep reduced tumor size and invasion significantly (Deb et al., 2013). A well-
accepted and simplified explanation for the oncogenic role of EZH2 is that EZH2 
inhibits the expression of tumor suppressor genes and DNA repair genes through 
the PRC2-dependent establishment of the silent chromatin that enriched with 
H3K27me3. A most recent study, however, suggested a PRC2-independent role 
of EZH2 in glioblastoma stem cells (GSC) (Kim et al., 2013). Following Akt 
mediated S21 phosphorylation, EZH2 can directly bind to and induce methylation 
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of lysine 180 (K180) of the STAT3 protein, leading to a sustained activation of the 
transcriptional activity of the STAT3 and the maintenance of the stemness of the 
GSC (Kim et al., 2013). S21 phosphorylation of EZH2 by Akt kinase has been 
first demonstrated in breast cancer cells treated with insulin-like growth factor I 
(IGF-I) or estrogen (Bredfeldt et al., 2010; Cha et al., 2005). In BEAS-2B cells, 
we had also noticed S21 phosphorylation of the EZH2 protein through the 
activation of the JNK-STAT3-Akt signaling axis in response to As3+ (Chen et al., 
2013).  
Arsenic has been shown to be highly capable of inducing ROS generation in 
a wide range of cell types. The data presented in this dissertation suggested an 
involvement of oxidative stress or ROS in the As3+-induced EZH2 
phosphorylation, which confirmed our previous findings showing that As3+ is able 
to induce ROS generation in the non-transformed BEAS-2B cells (Chang et al., 
2010). Further experimentation suggested that the phosphorylated EZH2 may 
contribute to the IRES-dependent translation of the c-myc oncogene. C-myc has 
been widely recognized as a promoter for cell proliferation (Kelly and Siebenlist 
1985, Lemaitre, Buckle et al. 1996). Indeed, cell viability test revealed cyto 
protective role of the cytoplasmic pEZH2 when the cells were cultured in the 
lower FBS (Fig.2.2.8 B). Thus, these findings established an additional 
oncogenic pathway induced by arsenic, that is arsenic-induced ROS may serve 
as an initial signal for the kinase activation and EZH2 phosphorylation, and the 
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phosphorylated EZH2 may contribute to c-myc oncogene translation through the 
IRES-dependent mechanism.  
Extensive studies had been made in the past few years on the role of non-
coding RNAs, especially the miRNAs, in the fine-tune regulation of genes and 
epigenetics under physiological and pathological conditions. It might be the first 
discovery that long-term treatment of the bronchial epithelial cells (BEAS-2B) 
induced overexpression of miR-214 and miR-199a that are able to down-regulate 
TFAM, leading to functional compromising of the mitochondria and metabolic 
shift of the cells. Metabolic reprogramming from mitochondrial OXPHOS/TCA to 
cytoplasmic glycolysis has been viewed as major driving force the 
carcinogenesis and the generation of the cancer stem-like cells.  Thus, these 
findings expanded our view on the mechanisms of arsenic-induced malignant 
transformation of the cells, that is, along with ROS and kinase-dependent EZH2 
phosphorylation and IRES-dependent c-myc translation, the impacts of miR-214 
and miR-199a on TFAM and mitochondrial dysfunction may serve as a parallel 
pathway in cooperation with the ROS-pEZH2-c-myc pathway for the arsenic-
induced carcinogenesis.  
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2.5 Materials and Methods 
2.5.1 Cell lines and reagents -- The human bronchial epithelial cell line BEAS-
2B was obtained from the American Type Culture Collection (ATCC, Manassas, 
VA). The BEAS-2B cells were cultured in Dulbecco's modified Eagle's medium 
(DMEM, Invitrogen, Grand Island, NY) containing 5% fetal bovine serum (FBS, 
Invitrogen), 1% penicillin/streptomycin, and 1% L-glutamine (Sigma, St. Louis, 
MO) at 37 °C humidified incubator with 5% CO2. The cells were treated with As3+ 
[arsenic (III) chloride, Sigma-Aldrich, St. Louis, MO], with the indicated 
concentrations and time when the cells reached an approximately 80% 
confluence. In some experiments, ROS scavenger N-acetyl-cysteine (NAC) were 
added 2h prior to As3+ treatment. 
2.5.2 Plasmid preparation and transfection -- Constructs of pcDNA3-3myc-
6His-EZH2 21D (S21D) and pcDNA3-3myc-6His-EZH2 21A (21A) were 
purchased from Addgene (Cambridge, MA). The plasmid DNA was amplified in 
DH5α Competent cells (Invitrogen, Grand Island, NY) and purified using HQ Mini 
Plasmid Purification Kit (Invitrogen) according to the manufacturer’s protocol.  
Cells in 6-well plates were transfected either with 50 ng plasmid DNA using 
Lipofectamine RNAiMAX Transfection Reagent (Invitrogen) or 2µg plasmid DNA 
with Nucleofector (Lonza, Anaheim, CA) with program G016.  
2.5.3 Cellular fractionation and Western Blotting -- For nuclear and 
cytoplasmic fractionations, a NE-PER nuclear and cytoplasmic fractionation kit 
(Thermo Scientific, Rockford IL) was used according to the manufacturer's 
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protocol. Fractions were then analyzed by regular Western blotting using GAPDH 
and lamin A/C as cytoplasmic and nuclear reference, respectively. For regular 
Western blotting, the cell lysates were prepared by RIPA cell lysis buffer (Cell 
Signaling, Danvers, MA) followed by ultrasonication and centrifugation. The 
supernatants were aspirated and proteins were quantified using a SpectraMax 
spectrophotometer (MDA Analytical Technologies). LDS sample buffer 
(Invitrogen) and dithiothreitol were added before denature. The samples were 
separated on 7.5% SDS-PAGE running gel and then transferred to PVDF 
membranes.  The membranes were blocked in 5% non-fat milk in TBST and 
incubated with the indicated primary antibodies at 4 ℃ overnight, and then 
incubated with second antibodies at room temperature for 1 h or 4℃ for 4 hours 
and washed with TBST 3 times for 10 min each.  The protein levels were 
detected using either SuperSignal West Pico (Thermo Fisher Scientific, Waltham, 
MA) or Immobilon Western chemiluminescent HRP substrate (MILLIPORE, 
Billerica, MA). The primary antibodies used in Western blotting include anti-
phospho-Akt (Ser473) (Cell Signaling), anti-phospho-Filamin A (Cell Signaling), 
anti-Filmain A (Cell Signaling), anti-Akt (Cell Signaling), anti-myc tag, (Cell 
Signaling), anti-GAPDH (Cell Signaling), anti-β-actin (Sigma), anti-phopho-
EZH2(Ser21) (Abcam), anti-phospho-JNK (Cell Signaling), anti-phospho-
Stat3(Ser 727) (Cell Signaling), anti-phospho-p38 (Cell Signaling), anti-phopho-
ERK (Cell Signaling), anti-EZH2 (Cell Signaling), anti- JNK (Cell Signaling), anti-
Stat3 (Cell Signaling), anti-p38 (Cell Signaling), anti-ERK (Cell Signaling), anti-
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GFP (Santa Cruz), anti-Lamin A/C (Santa Cruz), anti-c-myc (Cell Signaling), anti-
mdig (Invitrogen), anti-TFAM (Cell Signaling), anti-MT-ND1(Novus Biologicals), 
anti-ATP5a (Santa Cruz), anti-VDAC (Cell Signaling), and anti-Twist (Santa 
Cruz). 
2.5.4 siRNA Transfection -- Cells with a concentration of 1×105/ml were seeded 
into 6-well plates and transfected with siRNAs using Lipofectamine RNAiMAX 
reagent (Invitrogen). For short term treatment, 20 µM As3+ was added at 24 h 
and cultured for an additional 2h.  Control siRNA and siRNA specifically silencing 
Akt I and II were purchased from Cell Signaling (Beverly, MA).  
2.5.5 RT-PCR-- Total RNA was prepared by lysing the cells with TRIzol reagent 
(Invitrogen) according to the manufacturer’s protocol. The rapid isolation of 
mammalian DNA was prepared according to the protocol from Molecular Cloning. 
The reverse transcription and PCR were performed using Access Quick RT-PCR 
System (Promega) with 2 μg of total RNA and 0.3 μM sense and anti-sense 
primer. The mtDNA primer sequences as described in Dr. Ramos’ previous 
study(Ramos, Santos et al. 2009). The GAPDH primer sequences are: sense: 5′-
CTGAACGGGAAGCTCACTGGCATGGCCT-3′; antisense: 5′-
CATGAGGTCCACCACCCTGTTGCTGTAG-3′. 
2.5.6 Real-Time PCR-- Total RNA was extracted by TRIzol method and followed 
by reverse transcription using High-capacity cDNA Reverse Transcription Kits 
(Applied Biosystems). Each sample contains 0.2 μl dNTPs (100 mM, with dTTP), 
1 μl reverse transcriptase, 1.5 μl 10 × reverse transcription buffer, 0.2 μl RNase 
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inhibitor (20 U/μl), 1 μg total RNA, 5 × RT miR-214 or 199a primer (3 μl) and 
comparative volume of Nuclease-free water to the total volume of 15 μl. The 
miRNAs were quantified by real time PCR using TaqMan Small RNA Assays 
(Applied Biosystems) and 18S rRNA that was used as an endogenous control. 
For c-myc gene, the primers for reverse transcription are the 2 μl 10× random 
primers, and further analyzed by real time PCR using c-myc primer as 5’-
TACCCTCTCAACGACAGCAG-3’ and 5’-TCTTGACATTCTCCTCGGTG-3’ and 
SDHA as an endogenous control. . For TFAM and DNM3os gene, the primers for 
reverse transcription are the 2 μl 10× random primers, and further analyzed by 
real time PCR using TFAM primer as 5’-CATCTGTCTTGGCAAGTTGTCC -3’ 
and 5’-CCACTCCGCCCTATAAGCATC -3’, meanwhile DNM3os primer as5’-
CAGCCCTTGAGTGTGTCTCA-3’ and  5’-TACAACGGCATTGTCCTGAA-3’ with 
18s rRNA (primer 5’-GGCCCTGTAATTGGAATGAGTC -3’ and 5’-
CCAAGATCCAACTACGAGCTT -3’) as an endogenous control. 
2.5.7 Luciferase target validation assay-- The cells were seeded in 24-well 
plates at a density of 5 × 104/well. A TFAM (NM_003201) 3’-UTR clone in 
pMirTarget vector was purchased from Origene. The cells were transfected with 
the reporter constructs using Lipofectamine 2000 (Invitrogen) 24 h after plating 
according to the protocol provided by the manufacturer. Twenty-four hours after 
transfection, the cells were further transfected with miRNA precursor or inhibitor 
for anther 24 h, and analyzed by luciferase assay using the Luciferase Reporter 
Assay System (Promega) and a Glomax 20/20 luminometer (Promega). For the 
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c-myc IRES luciferase activity, the pRMF plasmid is a kind courtesy from Dr. 
Willis (University of Leicester, UK), and after transfection of pRMF construct for 
24 hours, either S21A or S21D EZH2 plasmid (Addgene) is further transfected for 
another 24 h, and after that the luciferase assay is conducted as described 
above. 
2.5.8 Metabolomics—For glucose flux, 3-4 million cells /sample in 10cm dish 
with three replicates were prepared, and get every sample exposed with 
4500mg/L U-13C glucose DMEM medium for 1 hour labeling (the concentration of 
glucose is same with the original culture medium glucose concentration). After 
labeling, remove medium and wash cells with cold 150mM ammonium acetate 
and get the buffer removed within 30 seconds. Quenching cells by pouring liquid 
nitrogen on the plate and allow evaporation until the majority of liquid nitrogen is 
gone. After the quick quench, wrap all of the plates with aluminum foil and store 
at -80ºC or put them on dry ice for shipment, the data were analyzed by 
University of Michigan Metabolomics or Metabolon Company(Untargeted Global 
Metabolomics). 
2.5.9 MicroRNA inhibitor and precursor -- The BEAS-2B cells or Transformed 
BEAS-2B cells were first seeded in a density of 2 × 105/ml into 6-well plates at 
37 °C with 5% CO2 for 24 h, then transfected with 60 nM miRNA precursor or 
inhibitor (Invitrogen) with Lipofectamine RNAiMAX reagent (Invitrogen). Opti-
MEM I Reduced Serum Medium (Invitrogen) was used to dilute nucleic acid and 
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liposome as suggested by the manufacturer. Protein levels were determined by 
Western blotting as described above. 
2.5.10 MTT cell viability assay – BEAS-2B cells were seeded in a 96 well plate 
with 10,000 cells each well, and after 24 hours of culture in 0.5% FBS 
supplemented medium, S21A or S21D EZH2 constructs were transfected to the 
cells according to the protocol for 24 hours. After 24hours of transfection, 10ul of 
5mg/ml MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-Diphenyltetrazolium Bromide) (MP 
Biomedicals,LLC) was added into each plate for 3hours’ incubation at 37 ºC 
incubator, and after incubation, aspirating medium and adding 100ul DMSO 
(Dimethyl sulfoxide) (Fisher Scientific) each well for further 30min shaking and 
after that absorbance was read at 570nm (formazan) and 690nm (reference) by 
Synergy H1 hybrid Reader (BioTek). 
2.5.11 Statistics-- Microsoft Excel was used for statistical analyses of the 
quantitative data. The data are expressed as the mean ± standard deviation (SD), 
and Student's t-tests were used to determine the statistical significance of 
differences between samples treated under different conditions. Differences were 
considered statistically significant when *p < 0.05. 
 
 
 
62 
 
 
 
CHAPTER 3 CONTRIBUTIONS OF ARSENIC-INDUCED CELL MIGRATION 
AND INVASION TO THE MALIGNANT TRANSFORMATION 
CHAPTERS CONTAIN MATERIAL FROM PUBLISHED WORK IN WHICH I 
WAS THE FIRST AUTHOR. THE CO-AUTHORS OF THESE PUBLICATIONS 
AGREE TO THE USE OF THE PUBLISHED DATA IN THIS DISSERTATION. 
3.1 Introduction 
In this chapter, we will discuss a relatively downstream effect of the arsenic-
induced malignant transformation, the metastasis and invasion. Metastasis refers 
to a process that cancer cells migrate to the secondary site(s) from their original 
tumor site, which occurred in almost all cancers that progressed to later stages. 
The first step of metastasis is the cell motility that drives cancer cell migration. 
Thus, we will aim at the underlying mechanisms of arsenic-induced cell migration 
and invasion. In human bronchial epithelial cells or lung cancer cells, we had 
shown that As3+ is able to activate protein kinase Akt through either inducing 
miR-190 or initiating the signaling cascade from JNK to STAT3 that contributes to 
Akt-dependent EZH2 phosphorylation, cell transformation and/or migration 
(Beezhold, Liu et al. 2011, Liu, Chen et al. 2012, Chen, Liu et al. 2013). Akt has 
long been viewed as a master regulator of epithelial-mesenchymal transition 
(EMT), cancer cell migration, invasion, and metastasis(Jiang and Liu 2009, Xue, 
Restuccia et al. 2012). Akt can directly phosphorylate ACAP1, Pak1, POSH, 
Girdin, and Twist that contain R-X-R-X-X-S/T or R-X-X-S/T Akt phosphorylation 
motif, followed by integrin recycling, actin cytoskeleton remodeling and 
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EMT(Manning and Cantley 2007, Dillon and Muller 2010). Hence, we 
hypothesized that pAkt substrate that responds to arsenic may be the regulator 
for arsenic-induced cell migration and further metastasis. Furthermore, ample 
evidence also indicates a positive role of ROS in cell motility enhancement 
(Nguyen, Zucker et al. 2011, Singh, Shankar et al. 2014).  
In addition to the capabilities of cancer cells in proliferation and apoptotic 
responses for colonization at the secondary site, the key event of metastasis is 
the cytoskeleton remodeling, detachment, polarization, and mobilization of the 
cells (Wu, Wu et al. 2008). In non-muscle cells, filamin A was the first discovered 
actin-filament crosslinking protein that interacts with integrins and several other 
cytoskeleton remodeling proteins (Nakamura, Stossel et al. 2011, Wickstead and 
Gull 2011, Savoy and Ghosh 2013). Intriguingly, this protein has also been 
confirmed as a substrate for some protein kinases, including FAK, Lck 
(Goldmann 2002), PAK1 (Hammer, Rider et al. 2013), MAPK (He, Kole et al. 
2003), and Akt (Ravid, Chuderland et al. 2008), indicating that phosphorylation of 
filamin A is an essential step in initiating filamin A interaction with the 
cytoskeleton remodeling proteins or integrins for cell migration (Chen, Kolahi et al. 
2009). In this chapter, we will further investigate the As3+-induced cell migration 
through ROS-dependent activation of Akt that phosphorylates filamin A at serine 
2152 in human bronchial epithelial cell line, BEAS-2B.  
3.2 Identification of Filamin A as the putative substrate for pAkt responsible 
for arsenic-induced cell migration. 
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During the processes of our research on the role of p-EZH2 in arsenic 
mediated signaling pathways, we hypothesized that arsenic induces EZH2 
phosphorylation and translocation through Akt activation. As an arginine (Arg, R)-
directed or AGC-family kinase, Akt can directly phosphorylate serine 
(Ser)/Threonine (Thr) in a conserved motif, RXRXXS/T, characterized by R at 
positons −5 and −3 (Alessiet al., 1996). Accordingly, proteins containing 
RXRXXS/T motif can be phosphorylated by Akt, which can be recognized by 
anti-RXRXXS*/T* motif antibody (anti-Akt substrate antibody, “*”  indicates 
phosphorylation). The human EZH2 protein contains RKRVKS21 motif that is in 
consensus with the conserved Akt phosphorylation site. To determine if As3+ can 
induce S21 phosphorylation of the exogenous EZH2 by Akt, the HEK-293 cells 
were transfected with a 3myc-tagged EZH2 followed by As3+ treatment. In the 
Western blotting results as shown in Fig. 3.2.1 A, the anti-Akt substrate antibody 
detected several bands with molecular weights around 170, 130, 95, 72, and 50 
kDa (Fig. 3.2.1 A, pointed by small triangles) in the cells treated with As3+.  
To test whether these Akt substrates are also present in other types of cells 
in response to As3+, we performed IP analysis using cell lysates from HEK-293 
cells cultured in the absence or presence of 20 μM As3+ for 2 h and an antibody 
specifically recognizing the phosphorylated Akt phosphorylation motif, R-X-R-X-
X-S/T. As depicted in Fig. 3.2.2A, a band with an estimated molecular weight 
about 280 kDa was constitutively detected in HEK-293 cells (pointed with a black 
block arrow). Treatment of the cells with As3+ enhanced the density of this band 
65 
 
 
 
considerably. Pre-incubation of the cells with an antioxidant, NAC that scavenges 
reactive oxygen species (ROS), diminished this band completely, suggesting that 
the occurrence of this band is ROS-dependent. To determine the nature of this 
protein band that can be recognized by an anti-Akt phosphorylation substrate 
antibody, we retrieved this band from Western blotting membrane and subjected 
it to proteomics analysis through tryptic digestion and peptide identification using 
orbitrap Fusion mass spectrometry as described under Materials and Methods. 
The peptides identified from this analysis suggested a possible presence of 11 
proteins in this protein band as detected in IP, among which only two proteins, 
filamin A and inositol 1,4,5-trisphosphate receptor type 3 (ITPR3), are within the 
range of molecular weight between 200 and 300 kDa where the original band 
was positioned. The filamin A was represented by 10 peptides, whereas ITPR3 
was represented by only 4 peptides. Thus, we concluded that the most abundant 
protein in this IP band is filamin A based on the assumption that the number of 
peptides identified in mass spectrometry is generally proportional to its 
abundance or concentration in the sample. 
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Figure 3.2.1 Both As3+ and H2O2 induce the interaction of Akt and EZH2 and 
Akt-dependent phosphorylation of the exogenous EZH2 overexpressed in 
HEK-293 cells. 
(A) HEK-293 cells were transfected with 3myc-tagged EZH2 expression vector 
for 24 h followed by the treatment of the cells with 20 μM As3 + for 2 h in the 
presence or absence of 10 mM NAC, followed by Western blotting using the 
indicated antibodies. (B) The transfected HEK-293 cells were treated with As3 + or 
H2O2, followed by Western blotting as in (A). (C), Anti-myc tag or control IgG was 
used in immunoprecipitation (IP) to pull down the exogenous myc-tagged EZH2. 
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The IP was then subjected to Western blotting using antibodies recognizing the 
phosphorylated Akt substrate motif (RXRXXS*/T*), myc tag, pAkt, and Akt. 
To further confirm filamin A as an Akt substrate, we next determined whether 
there is a direct interaction between protein kinase Akt and filamin A in BEAS-2B 
cells treated with As3+ through immunoprecipitation. Again, the anti-Akt substrate 
antibody was able to pull down filamin A in the cells treated with As3+ (Fig. 3.2.2C, 
top two panels). Using antibodies against either the total Akt or phospho-Akt 
(pAkt), we showed that both activated and total Akt were able to interact with 
filamin A that was phosphorylated at serine 2152 (S2152), and this interaction 
occurred only in the cells treated with As3+ but not the cells without As3+ 
treatment (Fig. 3.2.2 C). To exclude the possibility of non-specific protein-protein 
interaction during IP, we also used control IgG in our immunoprecipitation assay. 
It is clear that only the anti-pAkt antibody, but not IgG, can pull down the 
phosphorylated filamin A (Fig. 3.2.2 D). Therefore, these data provided 
substantial evidence indicating that filamin A is an endogenous Akt substrate that 
can be phosphorylated by Akt through direct interaction. 
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Figure 3.2.2 Identifying filamin A as an Akt substrate. 
(A), HEK-293 cells were treated with 20 μM As3+ in the presence or absence of 
10 mM N-acetyl L Cysteine for 2 h. Cell lysates were prepared using non-
denature buffer and subjected to immunoprecipitation (IP) using anti-Akt 
substrate antibody. Block arrow denotes protein band on the PVDF membrane 
that was retrieved for mass spectrometry analysis. (B), Mass Spectrometry 
results show the peptide profiling that overlaps sequence of filamin A. Top two 
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panels are representative spectrums of the peptides from filamin A. (C), BEAS-
2B cell were treated as in (A), and subjected to IP using the indicated antibodies 
followed by Western blotting (WB). (D), BEAS-2B cells were treated with 20 μM 
As3+ for 2 h, followed by IP using IgG or pAkt antibody as indicated and then WB 
using phospho-Filamin A (pFilamin A) or pAkt antibody. 
To extend above observations, we pretreated the cells with Wortmannin, an 
inhibitor that is relatively specific for the upstream kinase, PI3K that 
phosphorylates and activates Akt, in the BEAS-2B cells. A dose-dependent 
inhibition of the As3+-induced filamin A phosphorylation was observed in the cells 
pretreated with 10 or 20 μM Wortmannin that diminished Akt activation 
completely (Fig. 3.2.3A). This inhibitor had no detectable effect on the protein 
levels of non-phospho-filamin A, total Akt or β-actin (Fig. 3.2.3A). The 
requirement of activated Akt kinase in As3+-induced filamin A phosphorylation was 
further validated by silencing Akt using siRNA that specifically down-regulates 
Akt expression. As indicated in Fig. 3.2.3 B, the control siRNA with scramble 
sequence (siCtrl) has no inhibitory effect, neither on the level of phospho-filamin 
A (pFilamin AS2152) nor the total Akt. Silencing Akt using Akt specific siRNA (siAkt) 
not only reduced the levels of total Akt and the activated pAkt, but also 
attenuated phosphorylation of filamin A in the cells treated with As3+ (Fig. 3.2.3 B). 
Taken together, these data clearly suggest that the As3+-induced Akt activation, as 
determined by the phosphorylation on serine 473 (S473), is essential for the 
phosphorylation of filamin A at S2152.  
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We had previously demonstrated that As3+ induces excessive generation of 
ROS that contribute to Akt activation and the subsequent transformation of the 
cells(Chang, Pan et al. 2010). To address the role of ROS in As3+-induced filamin 
A phosphorylation, we first treated the cells with As3+ in the absence or presence 
of 20 mM NAC, a widely-used ROS scavenger. As expected, NAC prevented 
As3+- induced Akt activation and filamin A phosphorylation (Fig. 3.2.3 C). The role 
of ROS in As3+-induced filamin A phosphorylation was additionally confirmed by 
treatment of the BEAS-2B cells with 200 μM H2O2 for 5 to 60 min. Indeed, H2O2 
is able to induce Akt activation and filamin A phosphorylation in a time dependent 
manner. The activation of Akt and phosphorylation of filamin A can be detected 
as early as 5 min after the cells treated with H2O2. At 30 min, the filamin A 
phosphorylation reached plateau (Fig. 3.2.3 D).     
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Figure 3.2.3 As3+-induced Akt activation and Filamin A phosphorylation are 
ROS dependent. 
(A), BEAS-2B cells were treated with 20 μM As3+ for 2 h with or without 
pretreatment with 20 μM wortmannin. The protein levels of phospho-filamin 
AS2152, filamin A, pAktS473, Akt, and β-actin were determined by WB. (B), 
BEAS-2B cells were transfected with 50 nM Ctrl siRNA or Akt siRNA with or 
without an additional treatment of As3+ for 2 h. WB was then performed as in (A). 
(C), BEAS-2B cells were treated with the indicated concentrations of As3+ and/or 
NAC. WB was then performed as in (A). (D), Time-dependent induction of 
Filamin A phosphorylation by H2O2 in BEAS-2B cells. 
Accordingly, Filamin A belongs to the Filamin family, which plays a 
significant role in cytoskeleton remodeling. The three family members are Filamin 
A, B and C, and among them Filamin A was the first discovered actin-filament 
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crosslinking protein in non-muscle cells(Savoy and Ghosh 2013), it exerts its 
function as a cytoskeleton remodeler through several mechanisms, including: (1) 
crosslinking actin and filaments into systemic network; (2), anchoring the proteins 
for actin cytoskeleton; (3), interacting with integrins (Chen, Kolahi et al. 2009)and 
other transmembrane complexes (Rognoni, Stigler et al. 2012). Additionally, 
Filamin A is also reported to play a critical role in cell motility and migration (Chen, 
Kolahi et al. 2009, Nakamura, Stossel et al. 2011, Wickstead and Gull 2011). 
Based on these findings, we propose that arsenic enhances cell locomotion by 
activating Filamin A. 
Activation of Akt has been linked to a number of cellular processes, including 
cell growth, anti-apoptosis, transformation, migration, invasion, and metastasis of 
the cancer cells (Cheng, Lindsley et al. 2005). Accordingly, it is plausible to 
hypothesize that the activation of Akt by As3+ can be involved in cell migration. 
To test this, we first treated BEAS-2B cells with As3+ and then measured cell 
migration capability using Matrigel-based Migration Chambers. As3+ treatment 
promoted cell migration significantly (Figs. 3.2.4 A and C). Silencing Akt using 
Akt specific siRNA reduced the number of the migrated cells in response to As3+. 
As3+-induced cell migration was not affected by the control siRNA (siCtrl, Figs. 
3.2.4 B and C). 
To answer whether filamin A phosphorylation served as a downstream 
signal for As3+-induced Akt activation that facilitates cell migration, we next 
silenced filamin A by transfection of the cells with filamin A specific siRNA (siFlna) 
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followed by measuring the cell migration. Filamin A specific siRNA, siFlna, 
reduced the levels of both filamin A and the S2152-phosphorylated filamin A 
(pFilamin AS2152) notably (Fig. 3.2.5 A). The control siRNA, siCtrl, exhibited no 
significant effects on these proteins, neither pFilamin A, nor total Filamin A. In 
cell migration assays, again, As3+ increased the number of migrated cells 
significantly (Figs. 3.2.5 B and C). No inhibition of the As3+- induced cell migration 
was detected in the cells transfected with the control siRNA (siCtrl). In contrast, a 
strong inhibition of cell migration induced by As3+ was observed in the cells 
transfected with siFlna that specifically silences filamin A (Figs. 3.2.5 B and C). 
These observations, thus, not only reinforced the notion that filamin A might be 
an important regulator for cell migration(Ravid, Chuderland et al. 2008, Pena, 
Arderiu et al. 2012), but also provided strong evidence indicating that filamin A is 
a downstream effecter to bridge As3+-induced Akt activation and migration. 
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Figure 3.2.4 As3+-induced cell migration is Akt dependent. 
(A), Migration assay shows elevated motility of the BEAS-2B cells treated with 20 
μM As3+ for 24 h. (B), Silencing Akt by siRNA reduces As3+-induced cell migration. 
BEAS-2B cells were transfected with 50 nM control siRNA (siCtrl) or Akt siRNA 
(siAkt). (C), Semi-quantification of the migrated cells as shown in (B). Data are 
expressed as mean ± SD, n = 12, ***p < 0.001, **p < 0.01. 
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Figure 3.2.5 Silencing Filamin A prevented As3+-induced cell migration. 
(A), BEAS-2B cells were transfected with 50 nM control siRNA (siCtrl) or filamin 
A siRNA (siFlna) with or without treatment by 4 μM As3+ for 24 h. (B), 
Representative images of the migration assays. BEAS-2B cells were treated as 
in (A). C. Semi-quantification of the migrated cells as shown in (B). Data are 
expressed as mean ± SD, n = 12, *p < 0.05. 
Several lines of evidence had indicated the essential role of filamin A for 
mammalian cell locomotion. However, how this function of filamin A is regulated 
remains to be fully understood. Since As3+ induces direct interaction between Akt 
and filamin A (Fig. 3.2.2), which leads to S2152 phosphorylation of filamin A 
(Figs. 3.2.3 A and B), it is likely that the migration regulation by filamin A depends 
on the phosphorylation of filamin A at S2152. To explore this possibility, we 
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transfected BEAS-2B cells with an expression vector containing myc-tagged full-
length filamin A (myc-Flna, wild-type) or myc-tagged filamin A in which the serine 
2152 was mutated to alanine (S2152A). The substitution of S2152 with alanine 
abrogated the phosphorylation of filamin A as revealed in an IP experiment using 
anti-myc tag antibody (Fig. 3.2.6 A). Resembling the cells treated with As3+, cells 
with an overexpression of the full-length wild-type filamin A exhibited an 
enhanced migration capability (Figs. 3.2.6 B and C). On the other hand, the 
migratory ability of the cells expressing the mutated filamin A, S2152A, was 
much reduced relative to the cells expressing wild-type filamin A (Figs. 3.2.5 B 
and C). Thus, phosphorylation of filamin A at S2152 by As3+-activated Akt is a 
prerequisite step for cell migration. 
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Figure 3.2.6 Phosphorylation of Filamin A on Ser2152 is required for As3+-
induced cell migration. 
(A), BEAS-2B cells were transfected with 2 μg myc-filamin A (wild type, myc-Flna) 
plasmid or myc-filamin A S2152A (2152A) plasmid, followed by IP using anti-myc 
tag antibody and WB using the indicated antibodies. (B), Representative images 
of cell migration assay of the BEAS-2B cells that were transfected with 2 μg myc-
filamin A (myc-Flna) plasmid or myc-filamin A S2152A (2152A) plasmid. (C), 
Semi-quantification of the migrated cells as shown in (A & B). Data are 
expressed as mean ± SD, n = 12, *p < 0.05. 
To establish clinical relevance of the above findings, we investigated 
correlation between the expression level of filamin A and the survival times of the 
lung cancer patients by using an online database of Kaplan-Meier Plotter that 
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contains gene profiling information from 2,437 human lung cancer 
samples(Gyorffy, Surowiak et al. 2013). Three overlapping sets of probes are 
included in this database to mostly detect the open-reading-frame (ORF) of the 
filamin A mRNA. In initial analysis, we found that the expression level of filamin A 
did not distinguish poorer or better survival times of the patients when all types of 
lung cancers were included. After stratifying the lung cancer patients based on 
their status of cigarette smoking, e.g., never-smoked or smoked, it was found 
that higher expression level of filamin A predicts poorer overall survival of the 
patients who were never-smoked (Fig. 3.2.7 A). In contrast, higher expression of 
filamin A appeared to be no effect on the overall survival among those patients 
who were current or former smokers (Fig. 3.2.7 B). Since it had been well-
documented that cigarette smoking contributes to different histological subtypes 
of the lung cancer(Tse, Mang et al. 2009), we believed that the opposite 
predictive power of filamin A expression between smoked and never-smoked 
might be a reflection of the different histological subtypes of the lung cancers. 
Therefore, we next compared the overall survival of the patients with either 
adenocarcinoma or squamous cell carcinoma based on the higher or lower 
expression level of filamin A. It is true that higher level of filamin A predicts a 
significant poorer survival of the patients with adenocarcinoma (Fig. 3.2.7 C), but 
not the squamous cell carcinoma (Fig. 3.2.7 D). 
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Figure3.2.7 The expression level of filamin A is a prognostic factor for the 
lung cancer patients.  
A & B. High level of filamin A predicts poorer overall survival of the lung cancer 
patients who were never-smoked, but not those who were smoked. C & D. High 
level of filamin A predicts poorer overall survival of the patients with 
adenocarcinoma, but not those patients with squamous cell carcinoma. Statistical 
significance was determined by logrank p-values as indicated. The panels depict 
Kaplan-Meier survival probability with the probe ID 200859_x_at. Similar data 
were obtained when probe ID 214752_x_at and 2137 
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3.3 Discussion 
The molecular or biochemical basis of As3+-induced cell transformation, 
carcinogenesis and tumorigenesis is not well defined. In the present study, we 
identified a signaling cascade for As3+-induced cell migration. In both human 
HEK-293 cells and bronchial epithelial cell line BEAS-2B cells, our data suggest 
that As3+ induces activation of Akt that interacts with and phosphorylates filamin 
A, an actin-binding protein responsible for crosslinking actin filaments into the 
membrane glycoproteins and integrins(Nakamura, Stossel et al. 2011, Wickstead 
and Gull 2011, Savoy and Ghosh 2013).  Activation of Akt by As3+ appears to be 
ROS dependent, based on the fact that NAC, a widely used antioxidant, blocked 
As3+-induced Akt activation and the subsequent filamin A phosphorylation. This 
notion was additionally supported by the observation that H2O2, the most 
common intracellular oxidative molecule, can activate Akt, leading to the 
phosphorylation of filamin A. Silencing either Akt or filamin A using specific 
siRNAs impaired cell migration in response to As3+. Furthermore, our data also 
demonstrated that Akt-dependent phosphorylation on S2152 of filamin A is 
involved in cell migration, since overexpression of the mutated filamin A, in which 
S2152 was replaced with alanine, reduced the capability of cell migration. Taken 
together, these results provide the first evidence indicating that As3+ induces cell 
migration through signaling pathway from ROS to Akt that phosphorylates filamin 
A. 
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The association between environmental As3+ exposure and carcinogenesis 
had been well-established. Majority of studies so far addressed the potential 
effects of As3+ on the initiation of cell transformation and/or carcinogenesis, such 
as DNA damage responses, inhibition of the DNA repairing machinery, 
impairment of the immune surveillance system, alteration of the epigenetic 
modifications on the genome, and activation of a wide range of signaling 
pathways that linked to transcription factors and gene expression(Hubaux, 
Becker-Santos et al. 2013). Very limited information is available, however, on 
whether As3+ is also capable of regulating the key processes of tumorigenesis, 
including tumor cell motility, invasion and metastasis. Several reports as well as 
our previous studies had suggested that As3+ is a potent activator for the multi-
functional protein kinase Akt that had been linked to tumor angiogenesis, tumor 
cell metastasis and metabolism(Beezhold, Liu et al. 2011, Liu, Chen et al. 2012, 
Carpenter and Jiang 2013, Chen, Liu et al. 2013, Li, Qiu et al. 2014, Sun, Yu et 
al. 2014). Accumulating evidence has suggested that Akt can not only provide 
the cells with growth advantages by eliciting proliferative or anti-apoptotic signals 
but also engage with motility of the cells through regulating actin tethering and 
stress fiber assembly(Xue and Hemmings 2013). Thus, it is very likely that in 
addition to the earlier events of carcinogenesis, As3+ can also participate in the 
tumorigenic process through Akt activation. 
As revealed by IP using anti-Akt phospho-substrate antibody followed by 
proteomic analysis of the proteins in the immunocomplexes, we provide the first 
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evidence demonstrating a direct interaction between Akt and filamin A in cellular 
response to As3+. This interaction results in phosphorylation of filamin A at S2152. 
Akt-dependent phosphorylation of filamin A at S2152 has been previously 
determined in prostate cancer cells and the IGF-1-treated MCF-7 cells(Wang, 
Kreisberg et al. 2007, Ravid, Chuderland et al. 2008). It is believed that this 
phosphorylation can prevent cleavage of filamin A and enhance its association 
with caveolin-1. Few studies also implied that S2152 phosphorylation of filamin A 
by other protein kinases, such as PAK1 or RSK, might be involved in the 
formation of membrane ruffling and lamellipodia extension, the necessary steps 
for cell migration and tumor cell metastasis(Vadlamudi, Li et al. 2002, Woo, Ohta 
et al. 2004). Furthermore, studies using molecular dynamics simulations 
unraveled that phosphorylation of filamin A at S2152 can facilitate integrin 
binding of filamin A by conformational changes that open the primary binding site 
of integrin on the Ig repeat 21 of filamin A(Chen, Kolahi et al. 2009). Thus, an 
Akt-dependent phosphorylation of filamin A induced by As3+ may enhance the 
capability of integrin binding of filamin A, and consequently, foster migration of 
the cells. 
The observation that increased filamin A expression predicts poorer overall 
survival of the never-smoked patients and adenocarcinoma (Fig.3.2.7) provided 
compensatory supporting evidence suggesting involvement of filamin A in lung 
malignancy. More importantly, it is possible that this observation serves as a 
strong indication that this protein may impact the aggressiveness of the specific 
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histological subtypes of the human lung cancer. Many earlier studies had 
revealed that adenocarcinoma most likely occurred in the younger, never-
smoked and females with a much aggressive disease progression(Bourke, 
Milstein et al. 1992, Green, Fortoul et al. 1993). It is also noteworthy that there is 
an increased proportion of adenocarcinoma among U.S. copper smelter workers 
who were exposed to As3+ through inhalation(Wicks, Archer et al. 1981). Due to 
the higher frequency of mutation on the gene loci encoding LKB1, an extensively 
studied tumor suppressor that suppresses metastasis of the tumor cells, 
adenocarcinoma appears to be more metastatic compared with squamous cell 
carcinoma or large cell carcinoma(Sanchez-Cespedes, Parrella et al. 2002, Ji, 
Ramsey et al. 2007). As tumor cell metastasis is one of the major biological 
factors contributing to the aggressiveness of tumors, it is plausible, thus, to 
assume that increased level of filamin A can enhance the migration and 
metastasis potentials of the cancer cells, especially for the adenocarcinoma. 
Although phosphorylation status of filamin A on patient prognostic outcomes was 
not evaluated due to the unavailability of such data, a proportional increase of the 
phosphorylated filamin A can be envisioned among those patients with a higher 
level of overall expression of filamin A. Accordingly, the prediction of poorer 
survival of the never-smoked lung cancer patients with adenocarcinoma is in 
great agreement with our experimental findings showing As3+ induces Akt-
dependent phosphorylation of filamin A and cell migration. 
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In summary, this report presented a novel mechanism for the contributions 
of As3+ to human cancer. The data suggest that As3+ is capable of regulating the 
tumorigenesis through ROS dependent activation of protein kinase Akt that 
phosphorylates filamin A, leading to an enhanced crosslinking between actin 
filaments and integrin by filamin A and the subsequent migration of the cells. As 
cell motility or migration is one of the key steps for tumor cells metastasis 
(Moncharmont, Levy et al. 2014), regulation on the binding capability of filamin A 
on integrin and actin network certainly will influence the disease progression of 
the cancer patients. Indeed, a recent study showed that filamin A promotes 
migration and invasive potential of breast cancer cells through interaction with 
cyclin D1(Zhong, Yeow et al. 2010). This notion was further supported by the 
observations that overexpression of filamin A is associated with highly metastatic 
cancers, such as melanoma(Coughlin, Puig-de-Morales et al. 2006), 
neuroblastoma(Bachmann, Howard et al. 2006), breast cancer(Jiang, Yue et al. 
2013), and prostate cancer(Bedolla, Wang et al. 2009). Accordingly, the findings 
in this report may be potentially translated into new therapeutic strategies by 
targeting Akt kinase and filamin A in cancers resulting from exposure to As3+ or 
other environmental carcinogens. 
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3.4 Materials and Methods 
3.4.1 Cell lines and reagents -- The human bronchial epithelial cell line BEAS-
2B, and human embryonic kidney 293 cell line HEK-293 were obtained from the 
American Type Culture Collection (ATCC, Manassas, VA). The BEAS-2B cells 
were cultured in Dulbecco's modified Eagle's medium (DMEM, Invitrogen, Grand 
Island, NY) containing 5% fetal bovine serum (FBS, Invitrogen), 1% 
penicillin/streptomycin, and 1% L-glutamine (Sigma, St. Louis, MO) at 37°C 
humidified incubator with 5% CO2. The human embryonic kidney 293 cell line 
HEK-293 was maintained in DMEM containing 10% FBS, 1% 
penicillin/streptomycin, and 1% L-glutamine at 37°C humidified incubator with 5% 
CO2. The cells were treated with As3+ [arsenic (III) chloride, Sigma-Aldrich, St. 
Louis, MO], with the indicated concentrations and times when the cells reached 
an approximately 80% confluence. In some experiments, PI3K/Akt inhibitor 
Wortmannin or ROS scavenger N-acetyl-cysteine (NAC) were added 2 h prior to 
As3+ treatment. 
3.4.2 Plasmid preparation and transfection -- Constructs of pcDNA3-myc-Flna 
wild type (WT) and pcDNA3-myc-Flna S2152A were purchased from Addgene 
(Cambridge, MA). The plasmid DNA was amplified in DH5α Competent cells 
(Invitrogen, Grand Island, NY) and purified using either Plasmid Purification Kit 
(QIAGEN, Valencia, CA) or HQ Mini Plasmid Purification Kit (Invitrogen) 
according to the manufacturer's protocol. Cells in 6-well plates were transfected 
either with 50 ng plasmid DNA using Lipofectamine RNAiMAX Transfection 
86 
 
 
 
Reagent (Invitrogen) or 2 μg plasmid DNA with Nucleofector (Lonza, Anaheim, 
CA) with program G016. 
3.4.3 Western Blotting -- For regular Western blotting, the cell lysates were 
prepared by RIPA cell lysis buffer (Cell Signaling, Danvers, MA) followed by 
ultrasonication and centrifugation. The supernatants were aspirated and proteins 
were quantified using a SpectraMax spectrophotometer (MDA Analytical 
Technologies). LDS sample buffer (Invitrogen) and dithiothreitol were added 
before denature. The samples were separated on 7.5% SDS-PAGE running gel 
and then transferred to PVDF membranes. The membranes were blocked in 5% 
non-fat milk in TBST and incubated with the indicated primary antibodies at 4°C 
overnight, and then incubated with second antibodies at room temperature for 1 
h and washed with TBST 3 times for 10 min each. The protein levels were 
detected using CDP-Star Reagent (New England Biolabs, Ipswich, MA), 
SuperSignal West Pico (Thermo Fisher Scientific, Waltham, MA) or Immobilon 
Western chemiluminescent HRP substrate (MILLIPORE, Billerica, MA). The 
primary antibodies used in Western blotting include anti-phospho-Akt (Ser473) 
(Cell Signaling), anti-phospho-Akt substrate RXRXXS*/T* (Cell Signaling), anti-
phospho-Filamin A (Cell Signaling), anti-Filmain A (Cell Signaling), anti-Akt (Cell 
Signaling), anti-myc tag, (Cell Signaling), anti-GAPDH (Cell Signaling), and anti-
β-actin (Sigma). 
3.4.4 SiRNA Transfection -- Cells with a concentration of 1 × 105/ml were 
seeded into 6-well plates and reverse transfected with siRNAs using 
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Lipofectamine RNAiMAX reagent (Invitrogen). For short term treatment, 20 μM 
As3+ was added at 24 h and cultured for an additional 2 h. SiRNA that specifically 
silence filamin A was purchased from Santa Cruz Technology (Santa Cruz, CA); 
control siRNA and siRNA specifically silencing Akt were purchased from Cell 
Signaling (Beverly, MA). 
3.4.5 Immunoprecipitation (IP) and Proteomics -- After the indicated 
treatments, the cells were collected in IP lysis buffer and fragmented through 
passing the cells in a syringe equipped with 21.5 needle for 10–15 times. About 
500 μg protein for each indicated sample was prepared and then incubated with 
the specific antibodies that were conjugated with agarose beads at 4°C agitation 
overnight. The immunocomplexes were pulled down by centrifugation at 3,000 
rpm for 10 min and separated in SDS-PAGE gel for regular Western blotting. 
After extensive washes, the protein bands of interest on the PVDF membrane 
were retrieved with a scalpel followed by washing the membrane slices in double 
diluted water. Proteins on the membrane slices were digested overnight in 50 
mM ammonium bicarbonate, 30% acetonitrile and sequencing-grade trypsin 
(Promega, Madison, WI) at 37°C. The digestion solution was collected and the 
membranes were washed 2 times with 70% acetonitrile (ACN) and 1% FA with 
sonication. The solutions were pooled, speed vacuumed to dryness, and 
solubilized in 2% ACN, 0.1% FA. Protein peptides were separated by reverse 
phase chromatography (Acclaim PepMap100C18 column, Thermo Scientific), 
followed by ionization with the Nanospray Flex Ion Source (Thermo Scientific), 
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and introduced into an orbitrap Fusion mass spectrometer (Thermo Scientific). 
The obtained spectra were analyzed using Proteome Discoverer 1.4.0.288 
(Thermo Scientific) which incorporates the Mascot algorithm (Matrix Science, 
Boston, MA). 
3.4.6 Cell Migration and Invasion Assay -- Cell migration was determined 
using BD BioCoatTM MatrigelTM Migration Chambers (8 μm filter). BEAS-2B cells 
were seeded with a density of 1.5 × 104/well (siRNA transfection) or 1 × 105 /well 
(plasmid transfection) in the upper chamber. DMEM medium containing 5% FBS 
was added into the lower chambers. The chambers were incubated at 37°C for 4 
to 6 h, followed by replacing the medium contain 0.5% FBS and 4 μM As3+. After 
24 hrs incubation, the cells in the upper chambers were scrubbed out using 
cotton-tipped swab. The cells on the lower surface of the membrane were 
stained with the Diff-Quik Kit (Dade Behring). The migrated cells were counted 
under a microscope for 12 random fields in each group. 
3.4.7 Statistics-- Microsoft Excel was used for statistical analyses of the 
quantitative data. The data are expressed as the mean ± standard deviation (SD), 
and Student's t-tests were used to determine the statistical significance of 
differences between samples treated under different conditions. Differences were 
considered statistically significant when *p < 0.05, **p < 0.01or ***p<0.005. 
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ABSTRACT 
UNDERLYING MECHANISMS OF ARSENIC-INDUCED TUMORIGENESIS: 
FROM EPIGENETICS TO MALIGNANCY 
by 
LINGZHI LI 
August 2017 
Advisor: Dr. Fei Chen 
Major: Pharmaceutical Sciences 
Degree: Doctor of Philosophy 
Arsenic is a well-recognized environmental health threat with the capability 
of inducing a number of human diseases, including cancer. The aim of this 
dissertation is to unveil the mechanisms underlying the carcinogenic activities of 
environmental arsenic. The biological functions of arsenic had been studied for 
decades. However, there are still many questions that remain to be fully 
answered, such as whether and how arsenic contributes to the epigenetic 
regulations and migration or metastasis control of the cancer cells. In this regard, 
we focused our attention on both histone modifications and miRNA regulations in 
the arsenic-induced malignant transformation of the cells, and tried to establish 
the signaling cascades that mediate arsenic-induced transformation. Furthermore, 
we investigated the downstream functional pathways related to malignancy 
through biochemical and proteomics analyses. Based on the results from the first 
specific aim, we had demonstrated that long term treatment of the cells with 
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arsenic at concentrations that are comparable to environment arsenic exposure 
is able to induce EZH2 phosphorylation that facilitates its cytoplasmic localization, 
and the expression of c-myc. Meanwhile, we also noted that long-term treatment 
of the cells with arsenic induces expression of miR-214 and miR-199a along with 
a metabolic reprogramming of the cells from mitochondrial oxidative 
phosphorylation to cytoplasmic glycolysis (Warburg Effects). In the second 
specific aim, we further identified interaction of mdig and Filamin A 
phosphorylation that is involved in cell motility and migration induced by arsenic. 
Collectively, our studies on the novel pathways induced by arsenic provide new 
insights for the carcinogenetic mechanism of arsenic and shed light on the 
prevention and promising therapeutic strategies for human cancers that are 
associated with environmental arsenic exposure. 
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